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The purpose was to examine the cardiovascular response to an acute bout of 
handgrip exercise before and after non-dominant arm exercise training. 19 people 
participated in 16 sessions of exercise training and 16 participants acted as controls 
(age: 20±1yrs).  Blood flow measurements were taken at rest and following 3-min of 
forearm occlusion (RHBF) using plethysmography. Pneumotachometer, ECG, and 
blood pressure data were continuously collected during three testing conditions 
(spontaneous breathing (SB1: 5min), handgrip exercise (0.5hz) at 60%MVC with 
50mmHg of pressure on the arm (H60+50mmHg: 5 min), and forearm occlusion (FAO: 
3min)).  Data were analyzed for respiratory rate, mean R-R interval, standard deviation 
of normal RR intervals (SDNN), normalized units of low- (0-0.15 hz) frequency power 
(LFnu), and mean arterial pressure (MAP). There was no main effect of group or arm.  
There was a main effect of test condition such that respiratory rate 
(+3.10±5.40breaths/min), LFnu (+19.06±14.73%), and MAP increased 
(+24.51±21.15mmHg) and mean R-R (-247.11±129.70msec) and SDNN (-
45.16±40.65msec) decreased significantly during H60+50mmHg (non-dominant arm; 
p<0.05).  Respiratory rate (-0.10±4.84breaths/min), SDNN (-9.50±57.14msec), and 
LFnu (-1.64±18.34%) recovered to SB1 levels during. Mean R-R (46.11±106.57msec) 
and MAP (16.65±15.84mmHg) remained elevated above SB1 (p<0.05). There were 
positive linear associations between forearm circumference and Mean R-R and MAP 
during H60+50mmHg; and MAP during FAO. There was a negative linear association 
with forearm circumference and Mean R-R during FAO. There was no significant main 
effect or interaction with handgrip exercise training on any of the variables.  There was a 
 ix 
 x 
decrease in vascular resistance during RHBF (0.80±1.08 mmHg/ ml/100ml/min, p<0.05) 
in the arm that underwent exercise training. In conclusion, we found elevated MAP 
during FAO, which is indicative of significant EPR activity during exercise. Uniquely, we 
found linear associations between forearm circumference and the cardiovascular 
response to H60+50mmHg and FAO suggesting variation in the predominant 
mechanism of cardiovascular control.  We did not see an attenuation of cardiovascular 
responses to H60+50mmHg and FAO with exercise training. However, we did see a 
decrease in forearm vascular resistance during the reactive hyperemia condition in the 
exercise-trained arm.  
 
CHAPTER 1 INTRODUCTION 
 In response to the onset of exercise, heart rate and blood pressure rise to 
support working tissue. The initiation and magnitude of this response is a consequence 
of central and peripheral factors including higher brain center activity (anticipation of 
exercise) and mechanical compression and subsequent production of local metabolic 
by-products in the working musculature. Information from the higher brain centers and 
peripheral sites is received in various regulatory centers of the brain, which contribute to 
the modulation of various organs important in the exercise effort.  
 Arguably the most important regulatory center at the onset of the exercise effort 
is the cardiovascular control center located in the medulla oblongata. It is the 
cardiovascular control center, which enables rapid modulation of the cardiovascular 
system through parasympathetic withdrawal and increased sympathetic activation. The 
feedback loop between the local tissues involved in the exercise effort and the 
cardiovascular control center is known as the exercise pressor reflex.  It is believed that 
receptors originating in the exercising skeletal muscle detect movement and the 
presence of metabolites released during exercise, and signal the vasoregulatory center 
of the brain through specific afferent tracks resulting in an efferent autonomic mediated 
responses (Rowell, 1997; Mitchell, Kaufman, Iwamoto, 1983; Thomas, Chavoshan, 
Sander, Victor, 1998).   
The extent to which afferent information influences the autonomic response is 
poorly understood, but appears to have important clinical relevance. Recent literature 
suggests that dysfunction in skeletal muscle afferents may contribute to exercise 
intolerance in the elderly and those with heart failure (Piepoli, Ponikowski, Clark, 
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Banasiak, Capucci, Coats, 1999; Dinenno, Jones, Seals, Tanaka, 1999).  Before we 
can understand how to intervene in clinically significant changes in EPR, we need to 
better understand EPR function during acute exercise in humans and the plasticity of 
EPR to exercise training or pharmacology.  This may allow the development of 
treatment strategies for clinical populations effected by hypo- or hyperactive EPR.   
There are a number of approaches that have been developed to identify the role 
of EPR during exercise.  The EPR can be broken down into three distinct parts: the 
afferent arm of the reflex arc, the efferent arm of the reflex arc, and the end organ 
response to neural modulation via EPR.  
Models to evaluate the role of EPR during exercise also can be categorized 
according to the part (described above) of the EPR from which they derive their 
information.  The afferent models are considered the most highly controlled approach to 
evaluating the role of EPR during exercise, and directly measure afferent neural activity 
at the nerve or in the spinal cord.  Models employing this technique have been generally 
performed on animals.   
Alternately, direct nerve recordings from the efferent arm of the reflex arc can 
also be recorded and will be termed efferent models.  Although experimental control 
over central command is less complete in these models it is possible to perform efferent 
measurement techniques in both animals and people, nor does such an approach 
require surgery or anesthesia.   
The least invasive technique available to study EPR is the end organ approach.  
These techniques include measuring heart rate, heart rate variability, blood pressure, 
blood pressure variability, blood flow, and vascular resistance.  Although this approach 
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has the lowest level of experimental control, it can be performed on animals and people 
without the complications of invasive techniques and provides integrated information 
about cardiovascular control.   
Our lab has focused on using heart rate variability (HRV), an end-organ model, to 
measure autonomic modulation during exercise.  Using an exercise protocol developed 
by Victor and Seals (1989) we found a dose dependent decrease in Mean R-R interval 
to dynamic handgrip exercise at 20%MVC and 60%MVC.  However, MAP and low 
frequency normalized units (LFnu: an index of sympathetic modulation) increased only 
during 60%MVC handgrip exercise.  These current data agreed with the results from 
previous research using other methods to measure autonomic modulation (Victor and 
Seals, 1989).  
In addition to examination of the construct validity of this exercise protocol, we 
have also established the stability of cardiovascular responses to rest and exercise over 
a one-month period. Our data indicate that heart rate and indices of autonomic 
modulation are stable with R-values exceeding 0.72 at rest and during exercise (Kluess, 
Wood, Stone, Welsch, 2001). These values are consistent with previous reliability 
studies using heart rate variability to measure autonomic modulation of cardiovascular 
function (Amara and Wolfe, 1998; van de Borne, Montano, Zimmerman, Pagani, 
Somers, 1997).  Therefore we have demonstrated an ability to measure cardiovascular 
responses to acute exercise.   
The next step in this investigation was to test the specificity of the exercise 
protocol to the EPR.  Post-exercise forearm occlusion is a commonly used test to 
determine the contribution of the EPR to the exercise performed.  The theory is that if 
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EPR played a significant role in the muscle sympathetic and cardiovascular responses 
to exercise, then occluding the blood flow to the muscle after cessation of the exercise 
will result in a persistent elevation of muscle sympathetic activity and blood pressure 
due to continued stimulation of group IV afferents by the metabolites trapped in the 
muscle (Victor and Seals, 1989).   
This effect has been demonstrated in both isometric and dynamic exercise using 
afferent, efferent, and end-organ models (McClosky and Mitchell, 1972; Seals, 1989; 
Victor and Seals, 1989; Hayward, Wesselmann, Rymer, 1991; Somers, Leo, Shields, 
Clary, Mark, 1992).  While post-exercise forearm occlusion is a commonly used and 
accepted method to test for EPR activity during exercise, it is not without limitations.  
Using efferent or end organ models it is not possible to completely control, eliminate, or 
measure the influence of other cardiovascular control mechanisms that may also be 
acting on the system.  However, using post-exercise forearm occlusion does allow us to 
make weak, but potentially important, inferences regarding the contribution of the EPR 
to the cardiovascular response to exercise.  
Thus, we added post-exercise forearm occlusion to our current handgrip exercise 
model to evaluate the EPR specificity (Kluess, Wood, Stone, Wilson, Welsch, 2002).  
One problem we discovered with our current model is it did not result in statistically 
significant elevation of mean arterial pressure (MAP) above resting values in the control 
condition.  While this is a common problem in small muscle mass activity it 
nevertheless, suggests that we did not achieve an optimal stimulation of group IV 
afferents during the exercise stimulus (dynamic handgrip exercise at 60%MVC) 
(Somers et al., 1992). 
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In contrast to our study, Victor and Seals (1989) found that dynamic handgrip 
exercise at 60%MVC was a sufficient exercise intensity to induce persistent elevation of 
sympathetic activity and blood pressure during post exercise forearm occlusion.  One 
reason for this discrepancy between our study and Victor and Seals (1989) is that they 
used 2 minutes of exercise at 1 hz gripping frequency, while we used 5 minutes of 
exercise at 0.5 hz gripping frequency.  Although the total work in our study and Victor 
and Seals (1989) were roughly matched, it appears that gripping cadence may play a 
larger role in the magnitude of sympathetic activity produced during exercise than 
previously understood.  
In our original study, the participants had difficulty maintaining the 1 hz gripping 
frequency for five minutes.  Previous work by this lab has demonstrated that it takes 60 
to 90 seconds of handgrip exercise at 60% MVC (1 hz) to obtain a stable (steady state) 
heart rate (Kluess, Wood, Welsch, 2000).  One of the assumptions of frequency domain 
analysis is that the signal is stationary, thus, a five-minute data collection time during 
exercise is critical to allow at least two minutes of data to be obtained in the steady state 
period (Task force of the European Society of Cardiology and the North American 
Society of Pacing and Electrophysiology, 1996).  Therefore, we needed a change in the 
protocol that would increase sympathetic activity during dynamic handgrip exercise at 
60%MVC (0.5 hz), but not reduce the duration of the activity.   
Reducing metabolite washout by reducing the blood flow through the working 
muscle during exercise significantly increases the magnitude of sympathetic and 
cardiovascular response to a given exercise mode and intensity through increased  
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group III and IV afferents stimulation (Victor, Seals, Mark, 1987; Victor and Seals, 1989; 
Sinoway, Hill, Pickar, Kaufman, 1993; Adreani and Kaufman, 1998).   
Primary evidence for using reduced metabolite washout during exercise to 
induce skeletal muscle afferents is a study by Adreani and Kaufman (1998) using a 
decerebrate cat model.  They demonstrated that group III and IV afferents were directly 
stimulated with simulated walking activity with and without complete arterial occlusion.  
However, the magnitude of change in group III and IV afferent firing frequency to activity 
with arterial occlusion was 44% and 47% higher, respectively, than simulated walking 
without arterial occlusion.   
In humans exercise with reduced metabolite washout has also been used to 
induce EPR activity. Mostoufi-Moab, Widmaier, Cornett, Gray, Sinoway (1998) used 
cardiovascular response to dynamic handgrip exercise at 25%MVC with 50 mmHg of 
pressure on the arm as a measure of EPR activity.  A pressure of 50 mmHg on the arm 
has been well established as a pressure sufficient to occlude venous outflow, but have 
minimal influence on arterial inflow to the arm in humans (Cramer, Beach, Strandness, 
1983).  Therefore, exercise with 50 mmHg on the arm would cause metabolites to 
accumulate due to reduced venous outflow and stimulate the EPR.   
Additionally, Victor et al. (1987) performed dynamic handgrip exercise at 30% 
MVC with 50mmHg of pressure on the arm and found that it resulted in approximately 3 
fold greater heart rate and blood pressure response, compared to exercise with no 
pressure on the arm.  They specifically attributed the cardiovascular and muscle 
sympathetic nerve activity responses to greater stimulation of the EPR through 
increased trapping of metabolites during the activity.   
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Therefore, reducing metabolite washout by applying 50 mmHg to the arm during 
exercise is an established model to induce EPR activity using both afferent, efferent, 
and end-organ models. In efferent and end-organ models, it is not possible to 
completely attribute measures of autonomic modulation and cardiovascular response to 
the EPR.  However, when 50 mmHg of pressure is applied to the arm during exercise 
and is followed by forearm occlusion weak inferences can be made concerning the 
influence of the EPR during exercise.   
Thus, we have modified our protocol to maximize skeletal muscle afferent 
contribution by adding inflation of a blood pressure cuff to 50-mmHg to the high intensity 
exercise.  Occluding the arm during exercise has been shown to increase heart rate, 
blood pressure, and muscle sympathetic activity from 10 to 24% and should be a 
sufficient stimulus to optimally induce the EPR in the proposed study (Seals and Victor, 
1991; Victor and Seals, 1989; Victor et al., 1987).   
Subsequently, we wish to examine the effect of exercise training induced 
adaptations to EPR. To date, two studies have shown significant changes in 
cardiovascular responses to exercise with forearm occlusion and post-exercise forearm 
occlusion (Somers et al., 1992; Sinoway, Shenberger, Leaman, Zelis, Gray, Baily, 
Leuenberger, 1996; Mostoufi-Moab et al., 1998).  However, all studies have used a 
training stimulus below that which is known to induce an increase in sympathetic drive 
from skeletal muscle afferents (less than 60%MVC)(Seals and Victor, 1991). 
Additionally, the need to evaluate the training effect with an EPR specific test is 
important.  
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Mostoufi-Moab et al. (1998) and Somers et al. (1992) did use appropriate tests 
for EPR, but Somers et al. (1992) was not able to induce a significantly elevated MAP 
during post-exercise forearm occlusion either before or after training.  This suggests 
their exercise was not of a sufficient intensity to induce a large increase in sympathetic 
activity, previously established to be necessary to maintain group IV afferent activity 
during forearm occlusion (Victor and Seals, 1989).  
Sinoway et al. (1996) did not test or train at an intensity believed to induce a 
significant increase in sympathetic activity.  They concluded that the training 
adaptations from their protocol were due to mechanoreceptor adaptations, not 
metaboreceptor adaptations (Sinoway et al., 1996).  Therefore, the ability of the EPR to 
adapt to exercise training is still not well understood and there is a need for a training 
and testing protocol specific to the EPR. 
There is very little known concerning the chronic adaptations of the EPR.  
However, there is significant evidence that a change in autonomic modulation does 
occur with exercise training in as little as four weeks (Fisher and White, 1999; Schuit, 
van Amelsvoort, Verheij, Rijneke, Maan, Swenne, Schouten, 1999; Levy, Cerqueira, 
Harp, Johannessen, Abrass, Schwartz, Stratton, 1998; Seals and Chase, 1989; Somers 
et al., 1992; Mostoufi-Moab et al., 1998; Sinoway et al., 1996). Additionally, non-neural 
adaptations to exercise training such as vascular and skeletal muscle remodeling are 
known to be significant after four weeks of training and may indirectly influence EPR 
response to acute exercise and forearm occlusion (Sundberg, 1994 Mostoufi-Moab et 
al., 1998, Sinoway et al., 1996; Booth and Thomason, 1991; Laughlin, Oltman, and  
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Bowles, 1998).  Therefore it is reasonable to assume that four weeks of training will be 
a sufficient and appropriate training period to see changes in cardiovascular response 
related to EPR activity.  
Due to the non-specific nature of end-organ models to individual cardiovascular 
control mechanisms, it will not be possible to exclusively attribute training-induced 
changes in cardiovascular response to exercise and forearm occlusion to the EPR.  
However, using single-arm forearm training does provide an advantage over large 
muscle exercise in that the training effect is limited to the forearm and thus, changes in 
plasma volume, blood flow shunting, and other whole body adaptations will have a 
reduced effect on the cardiovascular changes observed (Fisher and White, 1999).   
Before we can understand how to intervene in clinically significant changes in 
EPR, we need to know if EPR is modifiable through training and/or pharmacology.  
Improved understanding of the mechanism of change in autonomic modulation with 
training and the adaptability of EPR will allow development of treatment strategies for 
clinical populations effected by hyper- or hypo-active EPR.   
Therefore, the purpose of this study was twofold: (1) to examine the 
cardiovascular response to an acute bout of handgrip exercise inasmuch as it may be 
reflective of stimulation of the EPR; and (2) to evaluate the influence of non-dominant 
handgrip exercise training on cardiovascular response to exercise and post-exercise 
forearm occlusion.  We hypothesized that the modified exercise protocol would result in 
persistent elevation of MAP and the index of sympathetic activity (LFnu) during post-
exercise forearm occlusion.  Additionally, we hypothesized that exercise training will  
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result in attenuated HRV and blood pressure responses to exercise and recovery in the 
trained arm.   
Previous studies have demonstrated that exercise training similar the current 
study, resulted in approximately 20% increase in maximal hyperemic blood flow 
following 5 minutes of forearm arterial occlusion (Alomari, Welsch, Prisby, Lee, Wood, 
2001).  Therefore, we hypothesized that blood flow would be higher in the trained arm 
following forearm occlusion compared to the control arm.  Consistent with other studies, 
we also expected to see no significant changes in MVC and forearm circumference 
(Alomari et al., 2001; Somers et al., 1992; Mostoufi-Moab et al., 1998; Sinoway et al., 
1996).  Additionally, we expected no HRV, blood pressure, blood flow, MVC, or forearm 
circumference changes in the no treatment group.   
1.1 Clinical Relevance 
 The extent to which afferent information influences the autonomic response is 
poorly understood, but appears to have important clinical relevance. Recent literature 
suggests that dysfunction in skeletal muscle afferents may contribute to exercise 
intolerance in the elderly and those with heart failure (Piepoli et al., 1999; Dinenno et al., 
1999).  Before we can understand how to intervene in clinically significant changes in 
EPR, we need to better understand EPR function during acute exercise in humans and 
the plasticity of EPR to exercise training or pharmacology.  This may allow the 
development of treatment strategies for clinical populations effected by hypo- or 
hyperactive EPR.   
Chronic changes in EPR sensitivity have been documented to occur as a result 
of aging and chronic heart failure.  These changes in EPR are associated with both 
 10 
decreased and increased EPR neural traffic and end organ response (Schuit et al, 
1999; Dinenno et al., 1999; Zelis, Sinoway, Leuenberger, Clemson, Davis, 1991; 
Sverrisdottir, Rundqvist, Johannsson, Elam, 2000). Investigations concerning the role of 
EPR in exercise intolerance and cardiovascular response in aging and heart failure 
need further development.  Establishment of exercise protocols as well as improved 
methods to study EPR contribution to autonomic modulation may aid in these studies.  
Additionally, the investigation of EPR as a contributor to exercise intolerance in other 
diseases such as peripheral vascular disease and diabetes should be advanced.   
There is very little known concerning the chronic adaptations of the EPR.  
However, there is significant evidence that a change in autonomic modulation does 
occur with exercise training.  Before we can understand how to intervene in clinically 
significant changes in EPR, we need to know if EPR is modifiable through training 
and/or pharmacology.  Improved understanding of the mechanism of change in 
autonomic modulation with training and the adaptability of EPR will allow development 
of treatment strategies for clinical populations effected by hyperactive EPR. 
1.2 Limitations 
1.  End-organ models provide only integrated information regarding cardiovascular 
control mechanisms.  Therefore, it is not possible to completely attribute any change in 
cardiovascular response to exercise or forearm occlusion to the EPR. 
2. Cardiovascular response to forearm occlusion may be confounded by factors such as 
baroreceptor sensitivity, pain response unassociated with group III and IV afferents, 
and/or changes in vascular function or control. 
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3.  The training effect for the EPR may occur later than four weeks, therefore, we may 
see no change in cardiovascular response to exercise.   
 
CHAPTER 2 LITERATURE REVIEW  
2.1 Introduction 
Cardiovascular control during exercise involves a complex system of redundant 
mechanisms that ensure adequate oxygen delivery to working muscles.  These 
cardiovascular control mechanisms are both central and peripheral with each providing 
unique information to the brain.  
The cardiovascular control center integrates information from all of the peripheral 
afferents and information from central command and the hypothalamus to create action 
through the autonomic branch of the nervous system.  This branch of the nervous 
system has two distinct parts called parasympathetic and sympathetic. The 
parasympathetic branch of the autonomic nervous system originates in the nucleus vagi 
in the medulla and innervates the heart through the vagus nerve.  The sympathetic 
branch of the autonomic nervous system originates in the cardiac accelerator nucleus of 
the medulla.  The sympathetic branch innervates both the heart and the vasculature.  
During exercise, the autonomic nervous system responds to reduce blood flow to 
non-working tissues and maximize blood flow to working tissues, while controlling blood 
pressure.  This occurs initially through a withdrawal of parasympathetic nervous activity 
and an increase in sympathetic nervous activity, which result in increased heart rate, 
stroke volume, and vascular resistance in the GI tract and non-working tissues 
(Fagraeus and Linnarsson, 1976; Peterson, Armstrong, Laughlin, 1988; Rowell, 1997).  
The signals to induce autonomic nervous stimulation to various parts of the body during 
exercise are from central command, the hypothalamus, the respiratory stretch  
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receptors, O2/CO2 receptors, the arterial and cardiopulmonary baroreceptors, and 
skeletal muscle afferents.   
Central command of cardiovascular control originates in the subthalamic 
locomotor region of the brain and acts to induce parasympathetic withdrawal and 
increase sympathetic activity by acting on the cardiovascular control center.  The 
hypothalamus is active during exercise where there is an increase in body temperature.  
Then the hypothlalmus acts to vasodilate the skin blood vessels (Brooks, Fahey, White, 
1996).   
In the respiratory system there are several receptors that influence 
cardiovascular control.  The respiratory stretch receptors are located in the chest wall 
and in muscles participating or assisting in respiration.  When activated, their role is to 
inhibit respiration.  Additionally, the respiratory system has receptors that detect O2, 
CO2, and pH.  These receptors decrease or increase breathing rate through the 
medulla to optimize body levels of these elements (Brooks et al., 1996).  In general, the 
arterial baroreceptors detect changes in arterial pressure and induce changes in 
autonomic nervous stimulation to maintain blood pressure within a narrow range.  Since 
blood pressure increases during exercise, the baroreceptors are believed to reset to a 
new maintenance point.   Therefore, during exercise the purpose of the baroreceptors is 
to maintain sympathetic activity and to prevent arterial hypotension (Rowell, 1997).  The 
mechanism by which baroreceptor resetting occurs is not well understood, but may be 
influenced by skeletal muscle afferents which originate in the nucleus tractus solitarii as 
does the arterial baroreceptors reflex (Machado, Castania, Bonagamba, Salgado, 
2000).   
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2.1.1 Skeletal Muscle Afferents 
Cardiovascular control during exercise is also influenced by receptors that detect 
movement and metabolites in the muscle.  Mechanoreceptors, such as golgi tendon 
organs and muscle spindles, detect movement and stretch within the tendons and 
muscle of active tissue.  These receptors have no direct link to the cardiovascular 
control center, but do exert some influence through central command and possibly 
through interneuron links in the spinal cord with other skeletal muscle afferents (Thomas 
et al., 1998; Brooks et al., 1996; Appelberg, Hullinger, Johansson, Sojka, 1983; 
Pedersen, Ljubisavljevic, Bergenheim, Johansson, 1998).  
One of the most interesting and controversial mechanisms of cardiovascular 
control originating in the skeletal muscle is the exercise pressor reflex (EPR).  
According to Rowell (1997), the purpose of these skeletal muscle afferents and their 
associated reflex is to "guard against hypoperfusion of the active muscle".  This reflex 
arc begins with receptors in the skeletal muscle and interstitial spaces, which detect 
metabolites and movement in the working muscle.  The information from the receptors 
is transmitted to the cardiovascular control center of the brain through afferent neurons 
called group III and group IV afferents.  The action of this reflex is to increase 
sympathetic nervous stimulation to metabolically active muscular movement.  
Therefore, stimulation of the EPR results in increased heart rate, blood pressure, and 
vascular resistance.  
Unlike mechanoreceptors, the EPR does have a direct connection with the 
cardiovascular control center of the brain.  Evidence suggests that the ventrolateral 
medulla is a critical region for expression of the EPR.  Li, Hand, Potts, Wilson, Mitchell 
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(1997), showed that the lateral reticular nucleus, the nucleus tractus solitarii, lateral 
tegmental field, the vestibular nucleus, the subretrofacial nucleus, and the A1 region of 
the medulla were activated with spinal stimulation to create static muscle contraction in 
anesthetized cats.  Additionally, there is evidence that the area postrema in the 
dorsomedial portion of the medulla is involved in modulating the nucleus tractus solitarii.  
The nucleus tractus solitarii is also the primary baroreceptor reflex location, and 
therefore may be the source of interaction between the baroreceptor reflex and the 
EPR.  Additionally, Bonigut, Bonham, Stebbins (1997) found that area postrema 
disruption resulted in enhanced blood pressure and heart rate response to static muscle 
contractions in anesthetized cats, suggesting that the area postrema plays an important 
role in baroreflex/EPR interaction.  There is evidence that the baroreceptor reflex acts to 
buffer the hypertensive effect of the EPR (Raven, Potts, Shi, 1997).  
The spinal cord is another source of EPR modification by peripheral 
mechanisms.  The spinal cord portion of this reflex is a complex system of interneurons 
that may be modified by intraspinal bradykinin and/or glutamate (Stebbins and Bonigut, 
1996; Adreani, Hill, Kaufman, 1996).  This is believed, although not well studied, to be 
the source of mechanoreceptor/EPR interaction (Appelberg et al., 1983).  
2.1.2 Morphology 
Group III and IV afferents are a family of unencapsulated nerve endings 
connected to afferent nerves.  Group III afferent endings are located in the interstitial 
space of the muscle, capillary walls, the venous vessel, the adventitia of lymph vessels, 
in connective tissue of the peritoneum, and in the collagen fiber bundles of the tendon 
(Andres, von During, Schmidt, 1985; MacLean, LaNoue, Gray, Sinoway, 1998).  The 
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afferent nerve of group III afferents are small (1-4micrometers), thinly myelinated nerve 
fibers with conduction velocities of 2.6 to 30 meters/second (Rotto and Kaufman, 1988; 
Thomas et al., 1998; Paintal, 1960).  Group IV afferents nerves are small (1-
4micrometers), unmyelinated nerves with conduction velocities less than 2.5 
meters/second (Andres et al., 1985; Rotto and Kaufman, 1988).  Group IV afferent 
endings contain granulated vesicles and most likely release protein neurotransmitters 
like substance P.  They are located extensively in the blood vessels, lymphatic vessels, 
and the interstitial space in the muscle (Andres et al., 1985; MacLean et al., 1998).  
Although we know a great deal about the distribution and basic anatomy of GIII and GIV 
afferents, the mechanism by which GIII and GIV afferents detect metabolites is, to date, 
undiscovered.  However, there is evidence that GIII and GIV afferents respond to 
metabolites such as lactate, adenosine, leukotrienes, prostaglandins, hydrogen ions, 
and potassium ions released by the muscle (Thomas et al., 1998).  
2.2 Models That Have Been Used to Evaluate EPR 
Despite more than 70 years of study a great deal of controversy still exists 
concerning the exercise pressor reflex (Mitchell et al, 1983).  From this controversy a 
number of hypotheses have arisen.  One set of hypotheses is the central command 
versus the exercise pressor reflex theory of cardiovascular control during exercise.  The 
Central command theory states that higher brain centers direct all cardiovascular control 
and motor unit recruitment during exercise, while the exercise pressor reflex theory 
states that peripheral mechanisms play an important role in cardiovascular control 
(Mitchell et al., 1983).  To date, there is good evidence that central command in 
combination with peripheral afferents influence cardiovascular control during exercise.  
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However, the set of stimuli that influences the predominance of one mechanism of 
cardiovascular control versus another is still under debate.   Within EPR literature, the 
sets of hypotheses are called the traditional versus the emerging hypothesis of EPR 
function.  The traditional hypothesis states that EPR only influences cardiovascular 
control under conditions where there is a mismatch between blood flow and skeletal 
muscle demand.  The emerging hypothesis states that EPR is active and influencing 
cardiovascular control both during low intensity exercise and under conditions where 
blood flow and demand are not matched (Thomas et al., 1998).  Past and current 
research has provided some insight into the validity of these hypotheses, but a great 
may questions still need answering to further understand the mechanisms of 
cardiovascular control during exercise.   
There are a number of approaches that have been developed to identify the role 
of EPR during exercise and test the exercise pressor reflex theory and the emerging 
model of metabolite-sensitive afferents in acute exercise.  The EPR can be broken 
down into three distinct parts: the afferent arm of the reflex arc, the efferent arm of the 
reflex arc, and the end organ response to neural modulation via EPR.  
Models to evaluate the role of EPR during exercise also can be categorized 
according to the part (described above) of the EPR from which they derive their 
information.  The afferent models are considered the most highly controlled approach to 
evaluating the role of EPR during exercise, and directly measure afferent neural activity 
at the nerve or in the spinal cord.  Models employing this technique have been generally 
performed on animals and tend to focus on central command versus EPR theory of 
cardiovascular responses to exercise.   
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Alternately, direct nerve recordings from the efferent arm of the reflex arc can 
also be recorded and will be termed efferent models.  Although experimental control 
over central command is less complete in these models it is possible to perform efferent 
measurement techniques in both animals and people, nor does such an approach 
require surgery or anesthesia.   
The least invasive technique available to study EPR is the end organ approach.  
These techniques include measuring heart rate, heart rate variability, blood pressure, 
blood pressure variability, blood flow, and vascular resistance.  Although this approach 
has the lowest level of experimental control, it can be performed on animals and people 
without the complications of invasive techniques and provides integrated information 
about EPR.  While each of these models has limitations, all have provided unique and 
valuable information regarding the role of EPR under various circumstances and the 
conditions under which EPR functions.  
2.2.1 Afferent Models 
The most powerful model providing information regarding the role of EPR in 
cardiovascular control during exercise is the decerebrate cat model.  In this model, the 
cerebrum of the cat is removed, thus eliminating central command by higher brain 
centers but allowing breathing, heart rate, and neural transmission to continue without 
the interference of anesthesia.  Exercise activity is produced at the spinal cord through 
stimulation of the ventral nerve roots.  This model has provided valuable evidence 
supporting the existence of the EPR and highlighting some of the characteristics of 
EPR.   
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The first study using this model was McMahon and McWilliams (1992).  Using 
electrical stimulation of the sciatic nerve (10 and 50 hz pulse of 1 ms duration - contract 
lasted 5 sec), McMahon and McWilliams (1992) found the latency of cardiac 
acceleration following muscle contraction was 687 ms and suggesting that early 
changes in R-R interval can be controlled from reflex activity in the working muscles.  
Additionally, a further increase in reflex R-R interval response was eliminated by a bolus 
of atropine indicating cardiac acceleration in response to muscular activity was due to 
vagal withdrawal.  
The characteristics of EPR were further explored by MacLean et al. (1998).  They 
used 3 and 5 hz twitch contractions of the sciatic nerve for 0.1 ms duration for 5 
minutes.  Additionally, they included micro dialysis probes in the muscle to measure 
intramuscular concentrations of metabolites to evaluate the most likely metabolite that 
stimulates EPR.  They found a dose dependent heart rate response, but MAP only 
increased at the highest stimulation rate.  Lactate, phosphate, hydrogen ions, and 
potassium ions were all elevated during both stimulation frequencies, however, 
following 10 minutes of recovery, lactate and hydrogen ion concentrations were still 
elevated even though heart rate and blood pressure had returned to normal.  Thus, they 
concluded that EPR is also stimulated during lower intensity longer duration activity and 
that potassium is the most likely metabolite stimulus for EPR activity.   
Another study by Adreani, Hill, Kaufman. (1997) showed that simulated walking 
activity in decerebrate cats directly stimulated the group III and IV afferents measured at 
the spinal cord.  A further study by Adreani and Kaufman (1998) demonstrated that 
group III and IV afferents were also directly stimulated with simulated walking activity 
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during arterial occlusion.  However, the magnitude of group III and IV afferent response 
to ischemic activity was 44% and 47% higher, respectively, than simulated walking 
without arterial occlusion.  Interestingly the hydrogen ion and lactate ion concentration 
in the venous blood was not significantly different in the ischemic and non-ischemic 
states, thus, suggesting that a metabolite other than H+ and lactate are responsible for 
EPR during ischemia.   
In summary, the decerebrate cat model has established that, in the absence of 
higher brain centers, a reflex originating in the muscle increases heart rate and blood 
pressure by initially stimulating vagal withdrawal.  This reflex operates at maximal 
isometric workloads, very low intensity dynamic activities, and under conditions of 
impaired blood flow which support the emerging model of EPR activity.  The response 
of this reflex appears to be dose dependent, but the metabolite that stimulates group III 
and IV fibers is still under investigation.  
Another method by which central control is reduced is the anesthetized animal 
model.  Although this model is less technically rigorous than the decerebrate cat model, 
the presence of anesthesia during testing may alter autonomic function and nerve 
impulses and thus, may change the behavior of the reflex or the actions resulting from 
an active EPR.  Despite the problems with this model, it has been used to provide 
important information concerning the characteristics of EPR under conditions of reduced 
input from central command.   
Rotto and Kaufman (1988) used this model to investigate the metabolic by-
product stimulating EPR activity.  They injected the femoral artery of anesthetized cats 
with lactic acid, arachidonic acid, adenosine, and phosphate at rest.  They found that 
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infusion of lactic acid (400mM) resulted in increased the discharge rate of 69% of the 
GIII and GIV afferents (latency time 5-10 sec) studied and caused an increase in arterial 
pressure in 22 out of 30 trials.  Arachidonic acid (AA) injection resulted in a 50% 
increase in discharge frequency (latency of 1-3 min) that lasted for 2-5 min after the 
injection.  The addition of indomethacin attenuated the response to AA by 83%.  
Interestingly, AA caused a decrease in arterial pressure of 10 to 76 mmHg in 33 out of 
59 trials.  Adenosine and phosphate caused 17% or fewer of the afferents studied to 
increase their discharge frequency at rest.  Therefore Rotto and Kaufman (1988) 
concluded that lactate and cyclooxygenase products are the most likely metabolites 
responsible for EPR.   
One of the more unique studies using this model was Sinoway et al., (1993).  
They found that group III discharge frequency increased with the injection of La at rest 
and decreased when dichloracetate (DCA), a drug that inhibits lactate dehydrogenase, 
was added.  However, repeated exposure to lactate at rest reduced the discharge 
frequency.  This reduction in discharge frequency was reversed by muscle contraction.  
Thus, suggesting that the metabolite receptors (group III afferents) have a relationship 
with receptors of movement (group IV afferents). 
In summary, this model has been primarily used to determine the metabolite(s) 
responsible for stimulating the EPR under conditions of reduced influence from higher 
brain centers.  Although still controversial, the results of these studies suggest that the 
most likely metabolites that stimulate EPR during isometric and dynamic exercise are 
lactate and cyclooxygenase products.  This conclusion is in conflict with the findings of 
MacLean et al. (1998) who employed a decerebrate cat model and inter-muscular 
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microdialysis.  While microdialysis metabolite collection is a superior method of 
determining physiological levels of metabolites that may effect EPR, MacLean et al., 
(1998) based their elimination of lactate as an important EPR activating metabolite on 
the evidence that HR and BP recovered from exercise before the lactate concentrations.  
Although higher brain centers were eliminated in their experiment, they failed to 
consider other autonomic reflexes that may play a predominant role during recovery 
from exercise, such as the baroreceptor reflex.  These findings do not conflict with the 
findings of Adreani and Kaufman (1998) that suggested that lactate may not be the 
predominant metabolite responsible for EPR activity during ischemia. Both of these 
models suggest strongly that there is a continuum of group III and IV afferents that 
respond to a variety of combinations of metabolites, muscular activity, and blood flow.   
2.2.2 Efferent Models 
Models like the decerebrate cat and anesthetized animal strongly support the 
existence of the exercise pressor reflex and have demonstrated that when central 
command is eliminated or reduced, this mechanism stimulates heart rate and blood 
pressure to increase.  These models also strongly support the emerging model of 
afferent contribution to cardiovascular control in that GIII and GIV afferents increased 
discharge frequency to low intensity electrical stimulation as well as maximal tetanic 
stimulation and ischemia.  However, these models have provided no evidence that this 
reflex plays a role during conscious activity and that the EPR occurs in humans to the 
same degree as cats and rabbits.   
Efferent models have become common to evaluate the role of EPR during 
various exercise protocols with recent improvements in the technique of 
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microneurography. Microneurography involves inserting a tungsten electrode into a 
nerve near the skin surface.  The electrode is moved until a signal consistent with 
sympathetic efferent activity is detected (Seals and Victor, 1991).  These data are 
commonly expressed as either the number of sympathetic bursts per minute or as 
sympathetic bursts per minute multiplied by the mean burst amplitude of the condition 
and in termed muscle sympathetic nerve activity (MSNA).   
The advantage of efferent models is that, although they are invasive, they do not 
require anesthesia.  Another advantage is that they measure peripheral sympathetic 
neural output as a result of reflex activity.  A disadvantage is these protocols cannot 
eliminate the contribution of central command to the sympathetic output measured and 
therefore cannot infer with a great deal of certainty that GIII and GIV afferent activity 
caused the sympathetic response measured in these experiments. However, an indirect 
approach for indicating GIII and GIV involvement used in efferent models is measuring 
peripheral sympathetic output during post-exercise ischemia.  This procedure 
theoretically prevents metabolites created during the previous exercise protocol from 
leaving the area and thus, continues to act on the GIII and GIV receptors.  Therefore, 
the result of this manipulation is that sympathetic outflow and, subsequently, BP 
remains elevated above rest, allowing the suggestion that the exercise responses were 
due to EPR activity (Seals and Victor, 1991).   
Despite the problems associated with efferent models, the experiments 
performed have provided valuable information regarding human sympathetic responses 
to various exercise protocols, active muscle masses, and magnitude of blood flow  
 24 
restriction. The most common exercise mode for use with microneurography recording 
is isometric exercise of the forearm, typically lasting from 3 to 5 minutes.   
Figure 2.1 summarizes the current literature regarding MSNA responses in 
bursts per minute to isometric exercise at varying exercise intensities (symbol F).  Each 
point represents the peak mean change from resting MSNA (range: 15 to 38 bursts/min) 
for each study. Isometric handgrip exercise results in a significant increase in the 
sympathetic activity going to the forearm even at exercise intensities as low as 10% of 
the participant's maximal voluntary contraction (MVC) in healthy adults (Saito, Iwatse, 
Mano, 1986; Seals, 1989). This dose dependent effect was also seen with significant 
mean changes in heart rate and blood pressure from rest.  However, blood pressure did 
not increase significantly until MSNA increased to 6 bursts per minute.  
Dynamic exercise has a much different pattern of nervous and cardiovascular 
response to exercise compared to isometric exercise.  The results from a number of 
studies using dynamic exercise intensities of 10% MVC to 60% MVC and a gripping 
frequency of 0.7 to 1 hz are summarized in figure 2.1 (symbol ∇).  Dynamic handgrip 
activity does not result in a significant increase in MSNA until 60% MVC.  However, the 
change in heart rate and blood pressure from rest occurs with dynamic handgrip 
exercise at 10%MVC (Victor et al., 1987; Victor and Seals, 1989; Saito et al., 1986).  
When larger muscle groups are used, such as with arm cycling (symbol  in figure 2.1), 
MSNA significantly increases from rest (25 burst/min difference) at 30% of MVC and is 
accompanied by heart rate (32 beats/min difference) and blood pressure (25 mmHg 
difference) changes (Victor et al., 1987; Victor and Seals, 1989). 
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Figure 2.1: Summary of MSNA results in bursts per minute  
for microneurography literature over different exercise protocols and 
exercise intensities.  
Intensity of exercise 







































Victor, 1989 Seals, 1989 
Seals, 1989 
Victor, 1989 




Therefore, the sympathetic response to isometric handgrip activity appears to 
have a lower threshold for increasing sympathetic activity and cardiovascular response 
than dynamic handgrip activity.  However, the magnitude of cardiovascular response at 
10 bursts/min above rest is greater with dynamic, than isometric handgrip exercise.   
Additionally, an increase in sympathetic activity during dynamic activity in larger 
muscle masses occurs at a lower relative workload than smaller muscle masses, but 
induces a larger magnitude change in sympathetic and cardiovascular response.  Seals 
(1993), comparing isometric handgrip exercise at 30% MVC and isometric abduction of 
the FDI muscle of the hand, further illustrated the muscle mass effect.  They found that 
both the magnitude of increase in sympathetic activity and cardiovascular response was 
2 to 3-fold greater in the larger muscle mass compared to the smaller muscle mass.   
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Reducing blood flow to the working muscle and following exercise also 
significantly increases the magnitude of sympathetic and cardiovascular response to a 
given exercise mode and intensity.  Victor et al., (1987) performed dynamic handgrip 
exercise at 30% MVC both with and without blood flow restriction.  Exercise with blood 
flow restriction resulted in approximately 3 fold greater heart rate and blood pressure 
response, compared to exercise with no restriction.  Additionally, dynamic handgrip 
exercise at 30%MVC with normal blood flow did not result in an increase in sympathetic 
outflow, but when blood flow was restricted during exercise MSNA was 16 bursts/min 
higher than rest.  This magnitude of change in sympathetic activity is similar to the 
magnitude of change seen with 35% of isometric activity (19 bursts/min above rest 
(Seals, 1989).   
Interestingly, the dose dependent effect described above does not occur with 
larger muscle masses.  Arm cycling with no resistance and blood flow restriction 
(250mmHg) resulted in a 2.7-fold greater heart rate, a 2-fold greater blood pressure 
response, and a sympathetic increase of 25-bursts/min above rest (similar to arm 
cycling at 30% normal blood flow).  However, arm cycling at 30% of the maximal 
workload with restricted blood flow resulted in only a 1.3-fold increase in HR, 1.6-fold 
increase in BP, and a 2.4-fold increase in MSNA, compared to the same exercise load 
with no blood flow restriction (Victor and Seals, 1989).  This protocol was also 
performed with 40 mmHg and 100 mmHg on the cuff during no load and 30% of the 
maximal load arm cycling activity.  These pressures did not result in a change in the 
sympathetic or cardiovascular response to the activity.   
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Post-exercise forearm occlusion is a commonly used test to determine the 
contribution of the EPR to the exercise performed.  The theory is that if EPR played a 
significant role in the muscle sympathetic and cardiovascular responses to exercise, 
then occluding the blood flow to the muscle after cessation of the exercise will result in a 
persistent elevation of muscle sympathetic activity and blood pressure due to continued 
stimulation of group IV afferents by the metabolites trapped in the muscle (Victor and 
Seals, 1989).   
Seals (1989) had their participants perform isometric handgrip exercise at 
35%MVC and then post-exercise occlusion.  They found a persistent elevation of 
muscle sympathetic activity and calf vascular resistance above resting values.  This 
effect did not occur when participants were allowed to recover without blood flow 
restriction.  In agreement with these findings, Somers et al. (1992) found a 270% 
increase in MSNA from rest during forearm occlusion following 33% isometric handgrip 
exercise.  However, heart rate and blood pressure were not significantly different from 
rest.  Following dynamic handgrip activity at 60%MVC, Victor and Seals (1989) found a 
persistent elevation of MSNA and blood pressure, but not heart rate with post exercise 
occlusion.  However, post exercise occlusion had no effect on neural or cardiovascular 
responses to dynamic handgrip exercise at 20%MVC.  
Data from both dynamic handgrip and arm cycling suggest that restricting blood 
flow lowers the threshold for increasing sympathetic activity and increases the 
magnitude of the cardiovascular response for a given intensity of activity.  MSNA 
appears to plateau in two arm cycling when blood flow is restricted regardless of the 
resistance on the flywheel.  These results from arm cycling activity suggest that there is 
 28 
an upper limit for increasing sympathetic activity in upper extremity activity.  
Additionally, post exercise occlusion appears to maintain exercise-induced increases in 
muscle sympathetic activity following both isometric and dynamic handgrip exercises.  
However, when the exercise did not result in a significant increase in sympathetic 
outflow, post exercise occlusion had no effect on neural or cardiovascular responses 
during recovery.   
2.2.3 End Organ Models 
The terminal end of any reflex loop is the target or end organ.  In the exercise 
pressor reflex, the target organs are the heart and the vasculature.  End organ models 
for EPR include measurements of heart rate, blood pressure, heart rate variability, blood 
pressure variability, blood flow, vascular resistance, and vascular conductance.  
Measuring the response of these organs has provided important information regarding 
autonomic control at rest and during exercise.  End-organ models are the least specific 
models to measure EPR influence over cardiovascular control, therefore, attributing the 
end organ response exclusively to the EPR is difficult.   
An advantage of these models is there are no mode, intensity, or muscle group 
restrictions for exercise in animals and people.  Additionally, end organ models are 
generally non-invasive, therefore, making it less likely that measurement itself is altering 
normal response and does not require anesthesia.  An added advantage of end organ 
models is both parasympathetic and sympathetic information can be inferred, allowing a 
more complete view of autonomic control of the cardiovascular system during exercise.  
Measurements of heart rate and blood pressure alone give us only very general 
information regarding autonomic modulation at rest and during exercise.  However, 
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analyzing heart period variation provides a unique measurement of autonomic 
modulation of the cardiovascular system.  
The theoretical framework for heart rate variability (HRV) as a measure of 
autonomic modulation is based on the cardiac tissue processing of signals from the two 
branches of the autonomic nervous system.  The parasympathetic branch of the 
autonomic nervous system releases acetylcholine at the post ganglionic synapse which 
acts directly on the SA node and atrial conduction fibers to open potassium channels 
and hyperpolarize the cells.  Acetylcholine is then rapidly broken down by 
acetylcholinesterase, which stops the hyperpolarization stimulus.  Therefore, 
parasympathetic neural activity has a very rapid tissue response to stimulation and a 
rapid recovery from stimulation, thus exerting its hyperpolarizing influence at a high 
frequency (0.15hz to 0.40 hz) (Task Force, 1996; Guyton and Hall, 2000).   
In contrast, the postganglonic fibers of the sympathetic nervous system release 
norepinephrine at the synapse, which stimulates beta-receptors to initiate the second 
messenger cascade for cAMP.  This eventually results in opening of calcium and 
sodium channels in the tissue and results in tissue excitability.  Sodium and calcium 
pumps removing the ions from the target cells cause recovery from sympathetic neural 
activation.  Therefore, sympathetic neural activity has a very slow onset of tissue 
response and a slow recovery from stimulation resulting in a low frequency of neural 
activity (0.04 hz to 0.15 hz)(Task force, 1996; Guyton and Hall, 2000).  
Predominant parasympathetic control of the heart results in high variation in the 
R-R interval due to the rapid onset and recovery of the cardiac tissue to 
parasympathetic nervous activity. Sympathetic stimulation of the heart results in a 
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higher heart rate with less variability because of the prolonged tissue excitability 
induced by sympathetic neural input.  Through this hypothesis it is possible, in general, 
to suggest that the standard deviation of the normal sinus R-R intervals (SDNN) indicate 
a predominant parasympathetic or sympathetic modulation of the heart rate (Task force, 
1996).   
Evidence to support SDNN as a measure of autonomic modulation is that when 
in animals or humans the Vagus nerve is cut, the SDNN decreases (Jokkel, Bonyhay, 
Kollai, 1995; Task force, 1996).  Additionally, during exercise, when parasympathetic 
withdrawal and increase in sympathetic stimulation are known to occur, SDNN 
decreases (Kluess et al., 2000; Iellamo, Pizzinelli, Massaro, Raimondi, Peruzzi, 
Legramante, 1999).  Studies using paced breathing to induce an increase in 
parasympathetic modulation of the heart have found an increased SDNN (Cooke, Cox, 
Dietrich, Taylor, Beightol, Ames, et al., 1998; Lee, Aucoin, Wood, Welsch, 2000; Wood, 
LeLeux, Welsch, Nelson, Kluess, Lee, 2001).  SDNN also has predictive validity.   
There have been a number of studies in adults and infants to suggest that lower 
SDNN taken over a 24-hour period predict an increased risk for sudden death 
(Lombardi, 2000).  However, SDNN does not discriminate between the modulation by 
branches of the autonomic nervous system and is influenced by the heart rate at which 
the measurement was taken, thus reducing the value of comparison between people 
and during exercise (Kluess et al., 2000).  
Another measure of heart rate variability is the frequency domain.  This 
technique is based on the previously mentioned frequency differences between the 
branches of the ANS.  Using frequency analysis, this technique attempts to discriminate 
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between R-R intervals occurring in a frequency band of parasympathetic neural 
stimulation of the heart (high frequency: 0.15 hz to 0.40 hz) and in a frequency band of 
sympathetic neural stimulation of the heart (low frequency: 0.04 hz to 0.15 hz) (Task 
force, 1996).   
The validity of assigning various frequencies to parasympathetic and sympathetic 
modulation is based on a number of studies.  Frequency distributions of the R-R 
intervals from people with heart transplants and animals after undergoing surgical 
vagotomy and sympathectomy have shown no power in the frequency bands assigned 
to ANS neural input (Task force, 1996). In neurally intact animals and humans, beta 
blockade resulted in a reduction in the low frequency power.  
 Using the parasympathetic blocker atropine reduced the power of the high 
frequency domain, but also decreased the power in the low frequency domain 
somewhat (Task force, 1996).  Exercise causes a reduction in the high frequency 
power, and an increase in the low frequency power, but also causes a reduction in the 
total power of the frequency spectrum (Iellamo et al., 1999; Gonzalez-Camarena, 
Carrasco-Sosa, Roman-Ramos, Gaitan-Gonzalez, Medina-Banuelos, Azpiroz-Leehan, 
2000). 
2.2.3.1 HRV as a Measurement of Autonomic Modulation 
Few studies to date have used to HRV as a measurement of exercise induced 
change autonomic modulation.  Fagraeus and Linnarsson (1976) reported that initial 
changes in heart rate during exercise were primarily due to parasympathetic withdrawal.  
Additionally Hollander and Bouman (1975) demonstrated, using pharmacological  
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blockade, that the decrease in R-R interval during low intensity exercise was mediated 
by vagus nerve activity without an increase in sympathetic drive.  
More recent work by Kurita, Takase, Hikita, Uehata, Nishioka, Nagayoshi, et al. 
(1999) found that heart rate, blood pressure, and high frequency power increased in 
response to isometric handgrip exercise, but low frequency power and cardiac 
norepinephrine did not change from rest to exercise.  Iellamo, et al. (1999) used 4 
minutes of static leg extension at 30%MVC followed by 5 minutes of post exercise leg 
occlusion.  They found normalized low frequency power increased with static leg 
exercise and remained high during post exercise occlusion.  High frequency normalized 
power decreased during exercise, but returned to baseline levels during post exercise 
occlusion.  They concluded that EPR was active during exercise and post exercise 
occlusion.  Heart rate was predominantly controlled by the baroreceptor reflex during 
post exercise occlusion, but blood pressure remained elevated due to EPR.  
Gonzalez-Camarena et al. (2000) compared the HRV response of isometric 
(30%MVC) and dynamic (30 to 60%VO2max, 60 rpm, 6 min) quadriceps femoris 
exercise.  Isometric exercise resulted in higher SDNN and heart rate compared to rest 
and both dynamic exercise intensities.  Low frequency and high frequency power was 
significantly higher during isometric exercise compared to rest and both dynamic 
exercise intensities.  The HF normalized units were higher with isometric exercise, 
compared to both dynamic exercise intensities.  They concluded that the cardiovascular 
responses to isometric and dynamic exercise are not controlled through the same 
mechanisms and speculated that the baroreceptor reflex may play a more dominant role 
in isometric compared to dynamic exercise.   
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Additionally, our lab has established the validity and reliability of using HRV as a 
measure of autonomic modulation during dynamic handgrip activity (Kluess et al., 2000; 
Kluess et al. 2001). We found a dose dependent response of heart rate, frequency 
domain indices of autonomic modulation and blood pressure during low (20%MVC) and 
high (60%MVC) intensity dynamic handgrip exercise. SDNN did decrease with exercise, 
but was not dose dependent.  These data agreed with the results from Victor and Seals 
(1989) using MSNA as a measure of sympathetic modulation.  Thus, we were 
successful in observing changes in autonomic nervous system modulation and that 
autonomic change was accompanied by dose dependent changes in heart rate and 
blood pressure.   
In addition to testing the constructive validity of this protocol, we have also 
established the stability of cardiovascular responses to rest and exercise over a one-
month period. Our data indicated that heart rate and indices of autonomic modulation 
are stable with R-values exceeding 0.72 at rest and during exercise (Kluess et al., 
2001).  These values are consistent with previous reliability studies using heart rate 
variability to measure autonomic modulation of cardiovascular function.  
Therefore, HRV can be used to assess autonomic modulation of the heart during 
rest and exercise with results that agree with efferent models. Iellamo, et al. (1999) 
demonstrated that HRV can be used to assess autonomic modulation during post 
exercise occlusion, and therefore, may be a suitable non-invasive tool to better 
understand the role of the EPR during exercise.   
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2.2.4 Blocking the EPR 
One of the problems with both efferent and end-organ models are the lack of 
specificity to a particular mechanism of cardiovascular control.  One method to 
overcome this problem is using a chemical that block the mechanism of cardiovascular 
control you wish to study.  A disadvantage of using a blocker is, by altering the 
response of one of the mechanisms of cardiovascular control, it may alter the behavior 
of other mechanisms.  Despite this disadvantage, blockers have been used to assess 
the role of EPR in cardiovascular control during exercise.   
Blockers that have been used in EPR research focus on reducing the amount of 
metabolite production during exercise.  Therefore, cyclooxygenase inhibitors, such as 
aspirin, ketoprofen, and indomethicin, which block prostaglandin production, have been 
successful in reducing the cardiovascular responses to exercise.  Additionally, 
dichloracetate and glycogen depletion, which reduces lactate production also, reduces 
EPR response.    
Rotto et al. (1990) found that Aspirin and indomethacin attenuated group IV 
afferent discharge by ~82% during a two stimulated muscle contractions in anesthetized 
cats.  Darques, Decherchi, and Jammes (1998) using aspirin and dicloracetate in 
paralyzed and anesthetized rabbits during exercise supported these findings.  They 
found a 44 to 75% decreased group III and IV afferent activity with the blockers during 
muscle stimulation with no change in resting afferent activity. 
  The effect of ketoprofen (1 mg/kg of body weight) in humans during static 
handgrip activity has also been studied.  Fontana et al. (1994) found a 55% decrease in 
respiratory frequency, 22% decrease in mean arterial pressure, and an 11% decrease 
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in heart rate.  EPR in humans also appears to be lactate sensitive. Sinoway, 
Wroblewski, Prophet, Ettinger, Gray, Whisler, et al. (1992) found a 12% decrease in 
blood pressure (BP) during post-leg exercise occlusion following glycogen depletion to 
reduce lactate production.   
Our lab has also attempted to develop a blockade model for EPR.  We used 
Aspirin (ASA) at doses of 80 mg, 325 mg, and 650 mg during low intensity dynamic 
handgrip exercise (20%MVC), high intensity dynamic handgrip exercise (60%MVC), 
forearm occlusion following 60%MVC exercise, and rest.  We found lower indices of 
sympathetic activity during post exercise forearm occlusion with 80 mg ASA; higher 
systolic blood pressure during post exercise forearm occlusion with 325 mg ASA; but 
higher spontaneous breathing R-R interval with 650 mg ASA compared to the control 
visit (Kluess et al., 2002).  
Our conclusions were that reduction in sympathetic activity during forearm 
occlusion with 80-mg of ASA was most likely a result of attenuated group IV afferent 
firing.  Additionally, ingestion of 325-mg of ASA resulted in increased systolic blood 
pressure during forearm occlusion and is consistent with changes in vascular 
compliance.  This effect was reversed with 650-mg of ASA and resulted in lower resting 
heart rate most likely a result of a change in intrinsic heart rate, rather than a change in 
autonomic modulation.   These findings suggest that aspirin influences cardiovascular 
control even during small muscle activity and suggest that aspirin in doses of 325-mg or 
more has a broad spectrum influence on the body (Kluess et al., 2002). 
 Therefore, chemicals that block the production of prostaglandins, leukotrienes, 
and lactate result in reduced group III and IV afferent firing in cats and rabbits.  In 
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humans, cardiorespiratory response to arm and leg activity is significantly reduced when 
chemicals that block the cyclooxygenase pathway or lactate production are used.     
2.3 Chronic Changes in EPR Activity 
While there is good evidence that the EPR exists, and responds to metabolic and 
movement stimuli, there is little evidence concerning EPR adaptations to exercise 
training. However, there is evidence that autonomic nervous system modulation 
changes as a result of exercise training in younger people and good evidence that 
exercise training alters autonomic modulation in older people, people with heart 
disease, and people with renal disease, but the mechanism of these changes are poorly 
understood (Levy et al., 1998; de Meersman, 1993; Ng, Callister, Johnson, Seals, 1994; 
Braith, Welsch, Feigenbaum, Kluess, Pepine, 1999; Deligiannis, Kouidi, Tourkantonis, 
1999; Duru, Candinas, Dziekan, Goebbels, Myers, Dubach, 2000; Stein, Ehsani, 
Domitrovich, Kleiger, Rottman, 1999; Hull, Vanoli, Adamson, Verrier, Foreman, 
Schwartz, 1994).   
2.3.1 Forearm Exercise Training 
Forearm exercise training is the most common mode for attempting to separate 
out various mechanisms of cardiovascular control because it allows some separation 
between changes in central command and peripheral mechanisms of cardiovascular 
control (Fisher and White, 1999).  Additionally, with forearm training, the training effect 
is limited to the forearm and thus, changes in plasma volume, blood flow shunting, and 
other whole body adaptations have a reduced effect on the cardiovascular changes 
observed.   
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Somers et al. (1992) had 8 men perform 6 weeks of dominant arm training at 
30%MVC.  They found no difference in heart rate or MAP response to isometric 
handgrip exercise at 33%MVC, but MSNA response was significantly lower during 
exercise and post exercise forearm occlusion following training.  Mostoufi-Moab et al. 
(1998) trained the non- dominant arm in 10 men, 5 days per week for 4 weeks at 
30%MVC.  They found that training had no effect on cardiovascular and metabolic 
response to rhythmic handgrip activity at 25%MVC.  However, when this exercise was 
performed with 50 mmHg of pressure on the arm, the trained arm MAP ()12 mmHg), 
lactate, and pH response to activity was decreased.  They concluded that the EPR was 
modified as a result of training.    
Sinoway et al. (1996) used the same training protocol as Mostoufi-Moab et al. 
(1998) and found an increased MSNA and forearm resistance and a decreased change 
from rest in lactate, MAP, arterial norepinephrine, and forearm blood flow during 
rhythmic handgrip exercise at 25%MVC.  Since they saw these changes at an exercise 
intensity that was below that which is believed to activate group IV afferents, they 
concluded that this training changes mechanoreceptors (group III afferents), but not the 
metaboreceptors (group IV afferents).    
One of the potential reasons that there are mixed results regarding forearm 
training and EPR is the intensity of the training itself.  All three studies mentioned above 
used a training intensity below that which is believed to induce an increase in 
sympathetic activity caused by EPR (Seals and Victor, 1991).  Additionally, the need to 
evaluate the training effect with an EPR specific test is important.  Mostoufi-Moab et al. 
(1998) and Somers et al. (1992) did use appropriate tests for EPR, but Somers et al. 
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(1992) was not able to induce a significantly elevated MAP during post-exercise forearm 
occlusion either before or after training.  This suggests their exercise was not of a 
sufficient intensity to induce a large increase in sympathetic activity, previously 
established to be necessary to maintain group IV afferent activity during forearm 
occlusion (Victor and Seals, 1989).   
Sinoway et al. (1996) did not test or train at an intensity believed to induce a 
significant increase in sympathetic activity.  They did see blood pressure and blood flow 
changes at 25%MVC which has not been previously shown.   However, Sinoway, et al. 
(1996) used an intra-arterial pressure gauge to measure BP. The higher sensitivity of 
this instrument as compared to auscultory BP measurements explains this result.   
2.3.2 Autonomic Modulation Following Exercise Training 
While forearm exercise training is the most specific method for identifying 
mechanisms of cardiovascular control changes with exercise training, there is little 
evidence to support EPR-specific changes in autonomic modulation.  However, there is  
good evidence that large muscle exercise does result in a change in autonomic 
modulation, both at rest and during exercise.   
Fisher and White (1999) used dynamic heel raise exercise training for 6 weeks 
and found a 28% reduction in diastolic blood pressure and heart rate to isometric 
exercise at 30% MVC, with no change in cardiovascular response to post exercise leg 
occlusion compared to pre-training.  However, they also observed a 24% decrease in 
diastolic pressure and heart rate in the untrained limb.  They concluded that the training 
resulted in adaptations to central command.   
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Schuit et al. (1999) had healthy people between the ages of 60 and 80 years 
aerobically train for 6 months.  They found a 6 to 15% increase in 24-hour HRV 
parameters following training.  Additionally, Stein et al. (1999) found a 13% increase in 
SDNN and a 30% increase in VO2max following 9 months of moderate intensity 
exercise training in people in their 60's.  
Short term HRV (collection time of 5 minutes or less) has not been used 
frequently for evaluating the training effect.  Levy et al. (1998) aerobically trained 
younger (range: 24-32 years) and older men (range: 60-82 years) for 6 months.  HRV 
was collected in two-minute intervals at rest and during each stage of a cycle ergometer 
graded exercise test.  They found a higher standard deviation of the normal R-R 
intervals (SDNN) in both groups and no significant difference between the groups 
following training.  The decrease in SDNN from baseline to 400 kpm was greater 
following training in both groups.   
Additionally, Seals and Chase (1989) reported a decreased forearm vascular 
resistance during lower body negative pressure following 30 weeks of vigorous aerobic 
training in middle aged men.  They concluded that the training resulted in a higher 
maximal exercise capacity, but did not change baroreceptor reflex control of the heart.  
The mechanism of attenuated forearm vascular resistance following training is not 
known 
2.3.3 Non-Neural Training Adaptations that Affect EPR  
It is possible that the EPR itself does not change with training, but exercise 
training results in non-neural adaptations that reduce the stimulus that induces EPR 
activity.  This may include skeletal muscle changes that reduce the amount of 
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metabolites produced during exercise, blood flow changes to the working muscle, or 
non-neural cardiovascular changes.   
Skeletal muscle metabolic, morphologic, and histological changes may influence 
EPR stimulation during exercise.  It is well known that exercise training results in an 
increase in mitichondrial volume, decreased blood lactate, and improved motor unit 
recruitment (Brooks et al., 1996). The magnitude of change from baseline in a given 
physiological variable is directly related to the intensity and amount of time the exercise 
is performed (Spina, 1999).  The time course of these changes depends largely on the 
variable measured, but is generally accepted to take 7 to 14 days to see a significant 
change in muscle proteins and blood lactate (for a comprehensive review see Booth 
and Thomason, 1991).    
 Additionally, there is evidence that restricting blood flow to the muscle being 
trained can amplify the training effect.  Using 4 weeks of leg exercise training with 50 
mmHg of pressure on the leg, Sundberg, 1994 found a 20% higher in VO2peak, ~20% 
higher citrate synthetase concentration, 30% higher capillary to fiber ratio, and 10% 
higher glycogen concentration in the leg trained with low blood flow compared to no 
training.  Previous work in afferent and efferent models have demonstrated that 
reducing blood flow to the working muscle is the most powerful stimulus for EPR activity 
and thus, should induce the largest magnitude change in EPR response to chronic 
activity.  
Improvements in blood flow with exercise training may also influence the activity 
of the EPR.  Vascular remodeling as a result of exercise training occurs at a very rapid 
rate.  Several studies have shown that 4 weeks of training results in increased vessels 
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diameter in humans.  Additionally, changes in NO production and vascular reactivity 
change in as little as 4 days (Laughlin, Oltman, Bowles, 1998).  
Other non-neural cardiovascular adaptations to exercise may also influence the 
EPR response.  Five months of long duration cycling training in young healthy men 
resulted in a decreased resting heart rate and increased VO2max, left ventricle 
diameter, septal thickness, and left ventricular volume in diastole.  These occurred 
without a significant change in heart rate variability (time and frequency domain) 
(Bonaduce, Petretta, Cvallaro, Apicella, Iannicieloo, Romano, et al., 1998).  These 
findings indicate that a change in intrinsic rate occurred rather than an alteration in 
autonomic modulation.   
There is limited evidence with forearm exercise to suggest that the EPR 
response to activity may change with exercise training.  However, there is good 
evidence that the autonomic nervous system response to rest and activity alters 
following a period of exercise training.  The contribution of the EPR to autonomic 
nervous system response both before and after training remains to be elucidated. 
 Additionally, the mechanism by which EPR alters with training is not well 
understood.  Currently methodology has not been able to distinguish whether the 
change in EPR activity is due to alterations in the stimulus (metabolic or blood flow 
changes) or is an adaptation of the reflex itself (reduced receptor sensitivity).  Better 
understanding of both the contribution of EPR to autonomic modulation during exercise 
and the mechanism by which the EPR response is modified will provide us with a better 
understanding of cardiovascular control.   
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2.4 Current Clinical Problems 
Chronic changes in EPR sensitivity have also been documented to occur as a 
result of aging and chronic heart failure.  These changes in EPR are associated with 
both decreased and increased EPR neural traffic and end organ response.  Although 
little information exists concerning EPR response in older individuals, there is consistent 
evidence of decreased HRV and higher efferent sympathetic nerve activity at rest and 
during exercise (Schuit et al, 1999; Dinenno et al., 1999).  
 Additionally, there is evidence that blood flow is lower and heart rate response to 
the onset of exercise is slower, and oxygen consumption is reduced compared to 
younger individuals (Brooks et al., 1996; Dinenno et al., 1999).  Another factor that may 
add to changes in EPR sensitivity is a loss of muscle mass and an increase in the 
percentage of slow twitch fibers in aging muscle (Brooks et al., 1996). Wilson, Dyke, 
Parsons, Wall, Pawelczyk, Williams, Mitchell. (1995) have shown that active fast twitch 
muscle has a higher EPR response than slow twitch muscle in rabbits.  Therefore, it is 
possible that changes in EPR response may contribute to autonomic modulation 
changes seen in older individuals.  
Considerably more literature exists linking EPR dysfunction with exercise 
intolerance in people with chronic heart failure.  In addition to very high sympathetic 
nervous activity in people with heart failure both at rest and during exercise, peripheral 
adaptations to chronic heart failure may contribute to abnormal EPR activity (Zelis et al., 
1991; Sverrisdottir et al., 2000).  
One of the modifications of the skeletal muscle to heart failure is a reduction in 
the number of slow twitch and an increase in the number of fast twitch fibers. 
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Concomitantly, there is an overall reduction in the capacity for oxidative metabolism in 
skeletal muscles of the whole body.  These changes result in greater lactate, potassium, 
and hydrogen ions all, which have a potent excitatory effect on GIII and GIV afferents in 
humans and animals (Zelis et al., 1991).  Impaired blood flow to the working muscle as 
a result of impaired blood shunting, vascular dysfunction, and poor venous outflow may 
also contribute to an elevated EPR response to activity (Zelis et al., 1991).   
Notarius, Atchison, Floras (2001) found a lower threshold and higher maximal 
activation for increase in MSNA with heart failure compared to controls during isometric 
and moderate intensity non-ischemic exercise.  Piepoli et al. (1999) also found evidence 
of hyperactive EPR in patients with heart failure.   In this study, all heart failure and 
control participants had an increase in systolic and diastolic blood pressure with post 
exercise occlusion, but magnitude of change was greater in people with more severe 
heart failure.  Additionally, they found significant correlations among ventilatory 
response to post exercise occlusion, peak VO2, and exercise intolerance.  They 
concluded that EPR is hyperactive in patients with heart failure and may contribute to 
feeling of breathlessness and exercise intolerance. 
Although the chronic adaptations to heart failure would suggest that EPR activity 
is elevated during exercise, there is some evidence that EPR is hypoactive in patients 
with heart failure. In agreement with studies named above, Negrao, Rondon, Tinucci, 
Alves, Roveda, Braga, et al. (2001) observed that MSNA at rest was related to disease 
severity.  However, they also noted that MSNA and forearm vascular resistance change 
with mild and moderate isometric handgrip exercise was not different among groups 
(controls, mild heart failure, and severe heart failure). Sterns, Ettinger, Gray, Whisler, 
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Mosher, Smith, et al. (1991) found that MSNA remained high in controls during post 
exercise occlusion, but declined in patients with heart failure. Additionally, Negrao et al., 
(2001) observed that post exercise occlusion resulted in persistent elevation in MSNA 
and MAP in people with mild heart failure and controls, but in people with severe heart 
failure, MSNA and MAP returned to control values.   
Therefore, considerable evidence exists to suggest that resting sympathetic 
activity to the periphery is high in people with heart failure and the magnitude of 
sympathetic activity is related to disease severity.  However, some controversy exists 
concerning changes in sympathetic activity during exercise in people with heart failure.  
There is little disagreement that sympathetic activity is higher during exercise in heart 
failure compared to controls, but some studies have shown that the change from rest to 
exercise is not different from control participants.  Information for post exercise forearm 
occlusion is also mixed and suggests that people with mild heart failure may have little 
to no hyperactivity in EPR response, but with more severe disease EPR may actually be 
hypoactive.   
Investigations concerning the role of EPR in exercise intolerance and 
cardiovascular response in aging and heart failure needs further development.  
Establishment of exercise protocols as well as improved methods to study EPR 
contribution to autonomic modulation may aid in these studies.  Additionally, the 
investigation of EPR as a contributor to exercise intolerance in other diseases such as 
peripheral vascular disease and diabetes should be advanced.   
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2.5 Conclusions and Future Directions 
EPR appears to operate under a complex system of sensitivity to metabolites 
and muscular movement, which needs to be taken into account when studying 
cardiovascular control.  Evidence suggests that multiple metabolites may be involved 
and related to the mode of exercise and the blood flow/metabolism mismatch involved.  
Further study concerning the conditions under which each metabolite(s) is most 
effective in stimulating EPR is vital to allow development of methodology to better 
isolate the EPR from other mechanisms of cardiovascular control.  Additionally, better 
understanding of the receptor and neural pathways associated with EPR would allow 
development of pharmacological tools to intervene when EPR is hyper- or hypo-active.   
EPR research is based on two basic sets of hypotheses.  One of these sets of 
hypotheses is the central command versus the exercise pressor reflex hypotheses of 
cardiovascular control during exercise.  The central command theory states that higher 
brain centers direct all cardiovascular control and motor unit recruitment during 
exercise, while the exercise pressor reflex theory states that peripheral mechanisms 
play an important role in cardiovascular control (Mitchell et al., 1983). Current 
knowledge about the EPR and other mechanisms of cardiovascular control cast 
significant doubt on the strict interpretation of the central command theory, however, the 
complex system of central command and peripheral cardiovascular control mechanisms 
is poorly understood.  
Observations in afferent models suggest that parasympathetic withdrawal is 
mediated by EPR.  However, evidence presented in efferent and end-organ models 
suggests that dynamic exercise has a higher degree of central command influence 
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compared to isometric exercise (Gonzales-Camerena et al., 2000; Illeamo et al., 1999; 
Seals and Victor, 1991).  This conflict among models concerning the central command 
and exercise pressor reflex theories may be explained by the suggestion that EPR has 
a weak parasympathetic control aspect, which is usually overwhelmed by the more 
powerful central command.  However, in afferent models (decerebrate cat/anesthetized 
animals) central command is eliminated or reduced which may allow this aspect of EPR 
to be expressed. 
The other set of hypotheses influencing EPR literature is the traditional versus 
the emerging hypothesis of EPR function.  The traditional hypothesis states that EPR 
only influences cardiovascular control under conditions where there is a mismatch 
between blood flow and skeletal muscle demand.  The emerging hypothesis states that 
EPR is active and influencing cardiovascular control both during low intensity exercise 
and under conditions where blood flow and demand are not matched (Thomas et al., 
1998).  Data from isometric handgrip, dynamic handgrip, arm cycling and isometric leg 
extension suggest that restricting blood flow to the working muscle lowers the threshold 
for increasing sympathetic activity and increases the magnitude of the cardiovascular  
response for a given intensity of activity and supports the traditional hypothesis (Saito et 
al., 1986; Victor et al., 1987; Seals, 1989; Victor and Seals, 1989).   
Afferent models (decerebrate cat) support the emerging hypothesis that low 
intensity dynamic exercise also induces EPR activity.  However, in humans the 
threshold for inducing EPR activity appears to be higher.  Efferent and end-organ 
models suggest that EPR is most active under conditions where blood flow is restricted 
for a period of time (occlusion or isometric exercise), but is active under conditions of 
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high intensity (60%MVC or greater) resisted exercise in the forearm and low intensity 
resisted exercise in the leg and upper body (30%MVC or higher).   Therefore, in an 
intact subject, the traditional hypothesis of EPR activity is partially supported in that the 
relative contribution of EPR is related to the degree of blood flow restriction in the 
working muscle.  However, EPR activity is also related to the size of the muscle mass 
used, and the amount of resistance to movement supplied by the activity, which 
somewhat supports the emerging hypothesis.   
Therefore, different models for evaluating EPR support the basic theoretical 
framework of the current hypotheses.  Future research should focus on developing 
models of EPR function that are non-invasive and involve minimal interference with 
other cardiovascular control mechanisms.  Additionally there is a need to move EPR 
research to more functionally significant models such as, lower limb exercise.   
There is very little known concerning the chronic adaptations of the EPR.  
However, there is significant evidence that a change in autonomic modulation does 
occur with exercise training. Before we can understand how to intervene in clinically 
significant changes in EPR, we need to know if EPR is modifiable through training 
and/or pharmacology.  Improved understanding of the mechanism of change in 
autonomic modulation with training and the adaptability of EPR will allow development 
of treatment strategies for clinical populations effected by hyperactive EPR. 
 
CHAPTER 3 MATERIALS AND METHODS 
3.1 Participants  
Volunteers (age 18 to 30 years of age) were asked to participate in this study. 
The sample size estimate for this study was based on a desired type I error rate of 5% 
and type II error rate of 20% and for a longitudinal study with a control group.   The 
calculation for the estimate made use of the effect size (ES), which was calculated as 
the smallest difference worth detecting divided by the expected standard deviation of 
the parameter of interest.  The calculation also made use of the test-retest reliability of 
the parameter (r).   
The primary variable of interest was the natural logarithm of normalized units for 
low frequency power (LFnu).  Therefore, we estimated the sample size based on the 
expected behavior of this parameter.  While the effect of exercise training on a reactivity 
measure, in general, has been documented in our laboratory, the magnitude of change 
in this variable following dynamic handgrip exercise was not known.  Therefore, we also 
estimated the sample size based on the expected values for reactive hyperemic blood 
flow (RHBF).  Our laboratory has previously documented training adaptations in RHBF 
following handgrip exercise training.  We used the most conservative of the two 
estimates for the determination of the sample size for the study.   
Estimating sample size using LFnu (Lee, 2001; Kluess et al., 2001):  
ES = smallest difference to detect  / standard deviation = 0.3units / 0.5 units = 0.6 
N = 32 / ES2 = 32 / 0.62 = 89 
n(total) = 2N(1-r) 
r for LFnu = 0.87 
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n = 178 (0.13) = 23.1 = 12 per group 
Estimating sample size using reactive hyperemic blood flow (RHBF)(Alomari et al, 
2001):  
Effect size = smallest difference to detect  / standard deviation = 5units / 8 units = 0.63 
N = 32 / ES2 = 32 / .632 = 80 
n(total) = 2N(1-r) 
r for RHBF = 0.93 
n = 160 (0.07) = 11.2 = 6 per group 
All volunteers were healthy adults without any overt signs such as diabetes, heart 
disease, hypertension, emphysema, gastrointestinal disturbances or bleeding or 
gynecological problems.  Individuals with any current medical problems (including those 
listed above), current infection, or on medication known to affect cardiovascular function 
were excluded from the study (see appendix B for the medical history questionnaire).  
Additionally, volunteers that had taken aspirin within two weeks prior to testing were 
excluded.   
3.2 Design 
This study involved an experimental design and made use of a mixed-model 
ANOVA to test for main effects of treatment and test condition as well as treatment by 
condition interaction.  There were two levels of treatment (trained arm vs. control) and 
two levels of conditions (pre versus post).  Additionally, the effect of the treatment was 
tested against two controls (internal control, i.e. dominant arm, and an external control, 
i.e., untrained non-dominant arms of age and gender matched participants). Thus the 
study made use of two mixed-model ANOVAS, one including an internal control, and 
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one including an external control.  A more complete description of the statistical 
comparisons is given in tables 3.1 to 3.6.   
3.3 Procedures  
Participants reported to the laboratory on two occasions for testing.  All visits 
were held prior to 11AM and participants were asked to refrain from eating, drinking, 
and exercising at least 12 hours prior to the test.  
3.3.1 Session 1  
Upon arriving at the laboratory, participants were asked some general questions 
about their health history in order to assess for the presence of any disease, condition, 
or medical therapy that might affect cardiovascular function.   
The circumference of both forearms was measured using a measuring tape at 
quarter distances from the midolecranon process to the ulnar styloid (sites 1-4, 
respectively).  While lying in a supine position, the participant was asked to squeeze the 
handgrip dynamometer attachment (Biodex Medical Systems, Shirley, New York) as 
hard as they could for 5-seconds.  They were allowed three trials with 30 seconds in 
between each trial.  The three MVC's were averaged and multiplied by 0.60 to derive 
the torque used during the exercise condition (60% MVC).  The participant was then 
instrumented with equipment to record blood flow, respiratory rate, ECG, and blood 
pressure (see diagram C.1 in appendix C for a diagram of instrumentation for testing the 
right arm).  
An EC-5R plethysmography system (Hokanson, 1995) with a mercury-in-silastic 
strain gauge and blood pressure cuffs on the arm and wrist were used to obtain forearm 
blood flow measurements. Blood pressure cuffs were positioned around the participant's 
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arm and wrist on the side to be exercised, and a mercury-in-silastic strain gauge placed 
around the forearm approximately 10 cm distal to the olecranon process for 
measurement of resting and post-occlusion blood flow.  The forearm was extended, 
slightly supinated, and supported by a Styrofoam block. Baseline blood flows were 
recorded at a paper speed of 5 centimeters/second and reactive hyperemia blood flow 
(RHBF) was recorded at a paper speed of 25 centimeters/second.  Additionally, a 
pneumotachometer was secured around the participant's torso and interfaced with the 
Biopac MP100 to measure respiratory frequency during the protocol. 
Heart rhythm was continuously collected using a 3-lead ECG interfaced with a 
Biopac MP100 and its companion software Acqknowledge (model MP100A, Biopac Inc., 
Santa Barbara, CA). All data was collected at 200hz.  Lastly, the non-working arm was 
fitted with a blood pressure cuff on the arm and a Colin 7000 tonometric sensor (Colin 
medical instruments, San Antonio, TX) on the wrist to measure blood pressure 
continuously throughout the protocol.  This was also interfaced with the Biopac MP100 
and the data was collected at 200 hz.  For a visual representation of the set-up for 
testing the right arm see appendix C diagram C.1.   
Baseline forearm blood flow measurements were obtained from the arm to be 
exercised. Immediately before the blood flow measurements, hand circulation was 
occluded for 1 minute by inflating the cuff at the wrist to 240 mmHg.  The arm cuff was 
then inflated to 50 mmHg and the baseline blood flow measurement was recorded. 
Following the resting blood flow measure, the arm cuff was inflated to 200 mmHg for 3 
minutes.  One minute prior to release of the arm cuff, the wrist cuff was inflated to 240 
mmHg.  RHBF was recorded at an arm pressure of 50 mmHg.   
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The participant was then asked to perform a handgrip exercise task preceded by 
5 minutes of quiet rest (spontaneous breathing, SB1). The handgrip exercise task 
consisted of squeezing a handgrip-measuring device once every two seconds at 60% 
MVC while the cuff on the arm was inflated to 50 mmHg for 5 minutes (H60+50mmHg). 
The participant had visual feedback regarding the amount of force they were exerting 
and an auditory cue for the cadence.  Additionally, they received verbal encouragement 
to maintain the force and cadence.  
Within the last 4 seconds of the exercising condition, the arm cuff was inflated to 
200 mmHg for 3 minutes (FAO).  Lastly, a blood flow measurement was obtained by 
inflating the wrist cuff one-minute prior to the release of the arm cuff.  The arm cuff 
pressure was reduced to 50 mmHg and a blood flow measurement recorded.  
Throughout the testing procedures, heart rate and blood pressure were recorded.  The 
testing procedures described above were repeated using the opposite arm as the 
working arm. The testing procedures for both arms lasted approximately 150 minutes.  
For a visual representation of the protocol time line see appendix C diagram C.2.   
Following testing, each participant was randomized to either non-dominant arm 
exercise training (training group) or the no training group.  The no training group 
(external control group) refrained from activities that specifically exercised the forearm 
muscles for 4 weeks.    
3.3.2 Exercise Training 
Participants reported to room 20 in the Gym Armory 4 days per week for 4 
weeks. Each day, the participant's resting maximal voluntary contraction in the non-
dominant arm was measured using a Lafayette instrument handgrip dynamometer.  The 
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participant was asked to perform a handgrip exercise for 20 minutes with their non-
dominant arm. The handgrip exercise task consisted of squeezing a handgrip-
measuring device once every two seconds at 60% of their resting MVC.  Participants 
were required to have an attrition rate of no less than 85%.   
3.3.3 Session 2 
Following 4 weeks of exercise training or the control period the participants 
repeated the protocol outlined in session 1.   
3.4 Data Treatment 
3.4.1 Blood Flow Analysis 
Blood flow was calculated as the rate of arterial inflow and reported in milliliters 
per minute per 100 milliliters of tissue (ml/100 ml/min).  Additionally, the change in blood 
flow from baseline to RHBF was calculated (delta BF=RHBF-baseline).  Vascular 
resistance was also calculated for the baseline and RHBF conditions as MAP/ blood 
flow.  The MAP collected during the SB1 condition was used for this calculation (taken 
approximately 90 seconds after the RHBF blood flow measurement).    
3.4.2 Pneumotachometer Data Analysis 
Pneumotachometer data was analyzed using Acqknowledge 3.0 software. 
Respiratory rate was obtained by counting the number of breathing cycles in a 15 
second period and multiplying this number by 4 to report the data in breaths per minute.  
The 15-second period was within the data segment described below for ECG and blood 
pressure wave analysis.  
For pre and post comparisons the data was expressed as an absolute change in 
respiratory rate from spontaneous breathing values.  Absolute change was calculated 
 54 
by subtracting the value obtained during exercise or forearm occlusion from values 
obtained during spontaneous breathing (absolute change with exercise = value during 
exercise - value during spontaneous breathing; absolute change with forearm occlusion 
= value during forearm occlusion - value during spontaneous breathing).   
3.4.3 ECG Analysis 
The ECG data was analyzed using Acqknowledge 3.0 software.  The ECG data 
was visually inspected for non-sinus beats and converted to a tachogram of R-R period. 
A custom made program in Matlab was used to analyze 2.2-minute segments of 
tachogram data for frequency and time domain parameters. Tachogram segments were 
taken from a representative section of data at least 90 seconds into the data collection 
of spontaneous breathing and H60+50mmHg; and sampled from the first 2.5 minutes of 
FAO.   
Raw data was reported as mean heart period (mean R-R), standard deviation of 
the normal sinus R-R intervals (SDNN), low frequency power (LF: 0.04 hz to 0.15 hz) 
and high frequency power (HF: 0.15 hz to 0.40 hz).  The frequency domain was 
additionally reported in normalized frequency units (LFnu: power / sum of LF + HF). For 
pre and post comparisons the data was expressed as an absolute change in Mean R-R, 
SDNN, LFnu from spontaneous breathing values.  The formula was absolute change 
with exercise (∆H60+50mmHg) = value during exercise - value during spontaneous 
breathing and absolute change with forearm occlusion (∆FAO) = value during forearm 
occlusion - value during spontaneous breathing).   
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3.4.4 Blood Pressure Analysis 
The blood pressure wave data was be analyzed using Acqknowledge 3.0 
software. Mean arterial pressure (MAP) was obtained by taking the mean of a 2.2-
minute blood pressure wave segment taken after the first 90 seconds of recording of 
spontaneous breathing and H60+50mmHg.  The 2.2-minute segment for FAO was 
obtained during the first 2.5-minutes of the recording.    
Using the segments described above, the data was also analyzed for the mean 
of the maximum blood pressure wave peak (systolic blood pressure, SBP) and the 
mean of the minimum blood pressure wave peak (diastolic blood pressure, DBP).  For a 
diagram of the parts of a blood pressure wave see appendix C diagram C.3.   
For pre and post comparisons the data was expressed as an absolute change in 
the condition (H60+50mmHg or FAO) from spontaneous breathing values.  Absolute 
change was calculated by subtracting the value obtained during H60+50mmHg 
(∆H60+50mmHG) or forearm occlusion (∆FAO) from values obtained during 
spontaneous breathing (∆H60+50mmHG = value during H60+50mmHg - value during  
spontaneous breathing; (∆FAO = value during FAO - value during spontaneous 
breathing).   
3.5 Statistical Analysis  
3.5.1 Participant Characteristics and Blood Flow 
A one-way ANOVA was used to evaluate pre-test between group differences in age, 
height, weight.  Additionally a one-way ANOVA was used to evaluate pre-test 
differences in the non-dominant arm between groups in arm circumference (sites 1-4), 
MVC, baseline blood flow, RHBF, delta blood flow, and vascular resistance.  A one-way 
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repeated measures ANOVA was used to evaluate pre-test differences between arms 
(dominant versus non-dominant) in the Training group for arm circumference (sites 1-4), 
MVC, baseline blood flow, RHBF, and delta blood flow.  The effect of the treatment 
between groups were evaluated in arm circumference and MVC using a 2 x2 mixed 
model ANOVA for arm circumference (sites 1-4), MVC, baseline blood flow, RHBF, and 
delta BF (See table 3.1).  
Table 3.1: Statistical comparison for treatment effect between groups using raw data 
2 levels of factor Pre Post 
Non-dominant external control group Raw data Raw data 
Non-dominant Training group Raw data Raw data 
 
The effect of the treatment within the training group was evaluated in arm 
circumference, MVC, and blood flow using a 2 x2 mixed model ANOVA for arm 
circumference (sites 1-4), MVC, baseline blood flow, RHBF, and delta blood flow.  See 
table 3.2. 
Table 3.2: Statistical comparison for treatment effect within groups using raw data 
2 levels of factor pre post 
Non-dominant arm  Raw data Raw data 
Dominant arm  Raw data Raw data 
 
3.5.2 Respiratory Rate, HRV, and Blood Pressure  
A 3x2 mixed-model ANOVA was used to evaluate pre-test differences among the 
conditions (SB1, H60+50mmHg, FAO) within groups in respiratory rate, mean R-R,  
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SDNN, LFnu (statistics were run using the natural log of LFnu due to the non-normal 
characteristics of the data), MAP, SBP, and DBP (table 3.3 and 3.4).  
Table 3.3: Statistical comparison for the effect of condition in the Training group on pre 
data only. 
3 condition (repeated measures) 
2 levels of factor SB1 H60+50mmHg FAO 
Non-dominant Raw data Raw data Raw data 
Dominant Raw data Raw data Raw data 
 
Table 3.4: Statistical comparison for the effect of condition in the external control group 
on pre-test data only.  
3 condition (repeated measures) 
2 levels of factor SB H60+50mmHg FAO 
Non-dominant Raw data Raw data Raw data 
Dominant Raw data Raw data Raw data 
 
A 2x2 mixed model ANOVA was used to evaluate the within group treatment effect 
using ∆H60 and ∆FAO for respiratory rate, mean R-R, SDNN, LFnu, MAP, SBP, and 
DBP (table 3.5).  
Table 3.5: Statistical comparison for within group treatment effect using change in 
absolute values from SB1 to H60+50mmHg or FAO 
2 conditions (repeated measures) 
2 levels of factor Pre Post 
Non-dominant arm  ∆H60 or ∆FAO ∆H60 or ∆FAO 




Additionally, the treatment effect between groups was evaluated using a 2x2 
(pre/post, non-dominant training group arm /non-dominant external control arm) mixed 
ANOVA using ∆H60 and ∆FAO for respiratory rate, mean R-R, SDNN, LFnu, MAP, 
SBP, and DBP (table 3.6).  
Table 3.6: Statistical comparison for treatment effect between groups using change in 
absolute values from SB1 to H60+50mmHg or FAO 
2 levels of factor Pre Post 
Non-dominant training group ∆H60 or ∆FAO ∆H60 or ∆FAO 
Non-dominant external control ∆H60 or ∆FAO ∆H60 or ∆FAO 
 
Alpha was set a priori at 0.05. A Tukey's protected T-test was used for post hoc 
analysis.  For the variables LFnu and MAP during ∆H60 and ∆FAO, post hoc analyses 
were performed to determine the observed type II error rate for the main effect of group, 
treatment, and the interaction. These are found in Appendix F.  
3.5.3 Associations Among Variables 
We evaluated the pre-test data for relationships among forearm circumference 
(site 1) and the absolute magnitude of change in the cardiovascular parameters (as 
compared to the SB1 condition, i.e., ∆H60+50mmHg and ∆FAO) for the variables Mean 
R-R interval, SDNN, LFnu, and MAP. We used linear regression modeling employing 
the least squares technique. Alpha was set a priori at 0.05.   
 
CHAPTER 4 RESULTS 
4.1 Participant Characteristics 
21 men and 19 women were recruited for participation in this study.  Nineteen 
participants were assigned to the external control group and 21 were assigned to the 
training group.  Over the course of the study, 3 participants were removed from the 
control group (1 woman and 2 men) and 2 participants were removed from the training 
group (2 men) due to non-compliance with the pre-test instructions or non-compliance 
with the training protocol.  There were no significant differences in participant 
characteristics between non-compliers and those who completed the study.  Table 4.1 
summarizes the final participant characteristics (taken at pre-test) for the groups.  
Table 4.1: Participant characteristics 









Men/Women 8/8 9/10  
Age 20.07±1.75 20.63±0.83  
Height (inches) 67.80±2.91 67.47±4.76  
Weight 161.53±28.57 168.89±34.07  
Arm circ site 1 pre(cm) 26.10±2.64 26.58±3.31 27.21±3.30 
Arm circ site 2 pre 23.30±2.37 23.13±3.32 24.26±3.35 
Arm circ site 3 pre 18.87±2.08 18.86±2.17 18.91±2.21 
Arm circ site 4 pre 16.28±1.24 16.68±1.56 16.45±1.37 
MVC pre (peak torque) 69.10±24.15 71.77±35.72 78.90±33.90 
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The external control and training group were well matched, inasmuch as there 
were no group differences in age, height, weight, non-dominant arm circumferences, 
and MVC. In addition there were no differences between dominant and non-dominant 
arm circumferences, and MVC within the training group.    
4.2 EPR effect (pre-data only) 
4.2.1 Respiratory Rate, HRV, and Blood Pressure 
There were no main effects of group or test condition (SB1, H60+50mmHg, and 
FAO) on respiratory rate (see figure 4.1).  However, there was a group by condition 
interaction such that respiratory rate was elevated above SB1 and FAO during 
H60+50mmHg, but only in the Training group during non-dominant arm exercise 
(H60+50mmHg = 19.58±5.56 vs. SB1 = 16.76±3.15 and FAO = 16.56±5.85 
Figure 4.1: Individual responses for respiratory rate to the 
conditions  in the non-dominant arm of the training group (pre-
test).  The bold line indicates the mean of the group.   * p<0.05 



























breaths/min; p<0.05).  Consequently, respiratory rate was used as a covariate in 
subsequent analyses of pretest data (Mean RR, SDNN, LFnu). There was no main 
effect of group on Mean R-R, SDNN, LFnu, MAP, SBP, or DBP.  However, there was a 
main effect of test condition on Mean R-R, SDNN, LFnu, MAP, SBP, and DBP.  Figure 
4.2 to 4.4 represents the individual responses in the training group in the non-dominant 
arm pre-training to SB1, H60+50mmHg, and FAO for the variables mean R-R, LFnu, 
and MAP.  
Post-hoc tests revealed that SDNN decreased during H60+50mmHg and 
returned to baseline with FAO for all groups.  See table 4.2 (H different from 
H60+50mmHg and * different from SB1).  Likewise, LFnu and SBP increased during 
H60+50mmHg and returned to baseline during FAO for all groups (see table 4.3 for 
SBP results; H different from H60+50mmHg and * different from SB1). 
Figure 4.2: Individual responses for mean R-R to the conditions 
in the non-dominant arm of the training group (pre-test).  The 




























Figure 4.3: Individual responses for LFnu to the conditions  in 
the non-dominant arm of the training group (pre-test).  The bold 




















Figure 4.4: Individual responses for MAP to the conditions  in 
the non-dominant arm of the training group (pre-test).  The bold 
























Table 4.2: The effect of condition on SDNN by group and arm (pre-test only). 









SB1 88.62±41.94 90.85±40.46 85.76±25.70 
H60+50mmHg 45.69±20.41* 46.96±15.07* 49.84±30.87* 
FAO 117.51±80.84H 87.14±42.02H 98.15±47.30H 
Mean±standard deviation 
Table 4.3: The effect of condition on SBP by group and arm (pre-test only). 









SB1 122.80±22.88 125.29±28.27 117.55±24.41 
H60+50mmHg 150.39±29.34* 142.77±43.56* 142.80±30.85* 
FAO 137.61±32.87 141.22±43.65 137.61±24.28 
Mean±standard deviation 
In the case of MAP, however, the post-hoc tests indicated that the values 
increased during H60+50mmHg and remained elevated during FAO (see figure 4.4).  
The main effects on mean R-R and DBP are modified by the appearance of group by 
test condition interactions (see table 4.4 for DBP results; H different from H60+50mmHg 
and * different from SB1).  
Similar to SDNN, the values for Mean R-R were lower during H60+50mmHg as 
compared to SB1 for all groups (see figure 4.2).  However, while the values tended to
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Table 4.4: The effect of condition on DBP by group and arm (pre-test only).  









SB1 69.69±25.10 68.54±18.52 56.82±19.37 
H60+50mmHg 86.96±22.23* 76.39±27.07* 76.86±21.18* 
FAO 77.50±27.70 79.52±30.24* 71.25±22.92* 
Mean±standard deviation 
return to baseline (SB1) during FAO, only the external controls returned completely to 
baseline.  With respect to DBP, the values increased during H60+50mmHg, and tended 
to return to baseline during FAO, but only completely recovered in the external control 
group.  
4.2.2 Associations Among Variables 
Additionally, we chose to evaluate the pre-test data for relationships among 
forearm circumference (site 1) and the absolute magnitude of change in the 
cardiovascular parameters (as compared to the SB1 condition), i.e., ∆H60+50mmHg 
and ∆FAO for the variables Mean R-R interval, SDNN, LFnu, and MAP.  We found no 
associations between circumference site and the ∆conditions for the variables SDNN or 
LFnu. However, ∆H60+50mmHg for the variable mean R-R was associated (Dominant 
arm (D): p=0.03, R2=0.14; non-dominant arm (ND): p=0.001, R2=0.26) with forearm 
circumference (slope: D=-14.79 msec*cm, ND=-22.11 msec*cm), where a larger 
decrease in mean R-R from SB1 to H60+50mmHg was associated with a larger arm 
circumference.  See figure 4.5 for a scatter plot of the data with the regression line.   
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Figure 4.5: Scatter plot and the linear regression for the association 








































There was also a significant association between ∆FAO for mean R-R to forearm 
circumference with (ND: p=0.03, R2=0.13; slope=14.11msec*cm), where mean R-R 
recovered to baseline levels more quickly with a larger arm circumference.  See figure 
4.6 for a scatter plot of the data with the regression line.  
Additionally, there was a significant positive correlation (slope=2.17 mmHg*cm) 
between the ∆H60+50mmHg for MAP (dominant arm) and forearm circumference 
(p=0.04, R2=0.13).  See figure 4.7.  ∆FAO for MAP was also associated with (slope: D=-
2.11 mmHg*cm) forearm circumference (D: p=0.03, R2=0.15).  See figure 4.8 for a 
scatter plot of the data with the regression line included.   
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Figure 4.6: Scatter plot and the linear regression  for the association 


































Figure 4.7: Scatter plot and linear regression for the association between 






































Figure 4.8: Scatter plot and the linear regression for the association 


































4.3 Effect of Training 
4.3.1 Participant Characteristics 
There were no main effects of treatment period or group by treatment period 
interactions on arm circumference at any site or handgrip MVC. Data is summarized in 
table 4.5.  
4.3.2 Blood Flow and Vascular Resistance 
The results of the mixed-model ANOVA revealed no main effect of treatment or 
group by treatment interactions for any of the blood flow or vascular resistance 
parameters (baseline, or during reactive hyperemia).  However, when a paired T-test 
was run on the non-dominant arm of the training group (i.e., the trained arm) there was 
a significant decrease in vascular resistance during RHBF with training (p=0.03).  A  
 68 
summary of individual response to the control condition in the dominant arm in figure 
4.9, and training in the non-dominant arm is in figure 4.10.  
Table 4.5: The effect of treatment for arm circumference and MVC 
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4.3.3 Respiratory Rate, HRV, and Blood Pressure  
Two separate 2 x 3 mixed model ANOVAs were conducted to examine main 
effects of group and treatment period and group by treatment period interactions on the 
∆H60+50mmHg and the ∆FAO for the variables respiratory rate, Mean R-R interval, 
SDNN, LFnu, MAP, SBP, and DBP.  One ANOVA included the internal control 
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(dominant arm of the training group), while the other employed the external control 
(Non-dominant arm of external control group).   
The results of the ANOVAs, in either case, revealed no main effects of group nor 
treatment period, nor group by treatment period interactions on any of the ∆conditions 
for the parameters indicated.  The means and standard deviations for the groups are 
summarized in tables 4.6 to 4.12.  
Figure 4.9: Individual responses for the change in vascular 
resistance during RHBF before (pre) and after (post) the 
































Figure D.1 to D.3 in appendix D represents the individual responses in the 
Training group in the non-dominant arm during FAO pre-training and post training for 
Mean R-R, LFnu, and MAP.  Additionally, post-test absolute values for SB1, 




Figure 4.10: Individual responses for the change in vascular 
resistance during RHBF before (pre) and after (post) training in 
the non-dominant arm of the training group. * p=0.03 using a 














































∆H60+50mmHg pre 2.42±6.23 3.59±4.87 4.26±6.51 
                           post 3.50±6.36 4.00±5.34 3.53±5.17 
∆FAO                 pre     -0.50±4.25 0.18±5.33 1.00±4.49 
                           post 2.07±4.01 1.41±4.73 0.78±4.86 
Mean±standard deviation 
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Table 4.7: The effect of treatment on mean R-R by group and arm 









∆H60+50mmHg pre -255.48±153.64 -240.83±112.31 -229.63±102.62 
                           post -221.33±97.34 -236.18±146.03 -223.52±131.00 
∆FAO                 pre     75.21±119.43 93.38±115.35 52.83±135.83 
                           post 59.74±96.28 83.44±109.70 35.95±136.90 
Mean±standard deviation 
Table 4.8: The effect of treatment on SDNN by group and arm 









∆H60+50mmHg pre -41.63±39.51 -47.80±42.30 -34.95±40.36 
                           post -52.43±42.59 -41.00±34.19 -49.60±33.61 
∆FAO                 pre     -29.23±76.91 6.29±27.45 12.25±103.17 
                           post -2.39±53.17 -9.23±30.27 -9.87±39.80 
Mean±standard deviation 
 While there were no statistically significant main or interaction effects noted, 
there appeared to be a trend toward a treatment by group interaction for SDNN 
(p=0.08).  The mean decrease in SDNN observed in the trained arm was of a smaller 
magnitude after the training period, whereas in the internal and external control arms, 
the mean decrease in SDNN was of a greater magnitude following training (see table 
4.8).  We also found a trend toward a main effect of treatment in SBP (p=0.08), where 
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both groups (non-dominant arm) decreased ∆H60+50mmHg from pre- to post-test (see 
table 4.11).  Lastly, we found a trend towards a treatment by arm interaction with 
∆H60+50mmHg in DBP (p=0.08).  In the training group, DBP increased from pre- to 
post-test in the non-dominant arm, but decreased in the dominant arm with 
∆H60+50mmHg (see table 4.12).    
Table 4.9: The effect of treatment on LFnu by group and arm. 









∆H60+50mmHg pre 18.71±14.04 19.33±15.59 11.74±16.24 
                           post 13.57±17.66 20.74±19.97 8.66±23.39 
∆FAO                 pre     4.63±20.85 -6.66±14.72 2.03±18.70 
                           post -1.61±18.27 -6.16±17.40 2.83±20.78 
Mean±standard deviation 
Table 4.10: The effect of treatment on MAP by group and arm 









∆H60+50mmHg pre 30.42±22.06 19.26±19.42 23.20±20.09 
                           post 17.47±12.17 19.42±13.93 16.99±13.22 
∆FAO                 pre     19.44±21.53 18.74±20.09 12.89±21.30 
                           post 15.09±13.16 14.06±19.52 10.26±20.73 
 Mean±standard deviation 
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Table 4.11: The effect of treatment on SBP by group and arm 









∆H60+50mmHg pre 27.59±24.58 18.28±25.52 25.26±24.49 
                           post 13.44±13.13 13.64±18.20 14.93±17.27 
∆FAO                 pre     14.81±28.25 16.85±27.23 20.07±26.05 
                           post 10.85±11.19 8.99±24.73 15.79±20.39 
Mean±standard deviation 
Table 4.12: The effect of treatment on DBP by group and arm 









∆H60+50mmHg pre 22.28±21.72 8.86±20.42 20.04±16.21 
                           post 16.99±11.25 17.38±13.62 15.17±11.52 
∆FAO                 pre     12.29±25.01 9.82±22.60 14.43±17.31 
                           post 12.55±13.02 7.79±17.92 12.13±12.34 
Mean±standard deviation 
4.3.4 Other Measurements 
Participants did improve their training time from the first week (average training time: 
17±5minutes) to the last week (20±2minutes, the training time was limited to 20 minutes 
per session, p<0.05).  Additionally, participants reported an average RPE of 13±2 the 
first week and 15±8 the last week of training (not significant).  
CHAPTER 5 DISCUSSION 
The purpose of this study was twofold: (1) to examine the cardiovascular 
response to an acute bout of handgrip exercise in as much as it may be reflective of 
stimulation of the EPR; and (2) to evaluate the influence of non-dominant handgrip 
exercise training on cardiovascular response to exercise and post-exercise forearm 
occlusion.   The results indicate that we were successful in establishing a model with 
cardiovascular responses consistent with stimulation of the EPR. With respect to the 
influence of exercise training, we hypothesized that exercise training would result in 
attenuated HRV and blood pressure responses to exercise (H60+50mmHg) and 
recovery (FAO) in the trained arm.  Exercise training did not result in an attenuated HRV 
and blood pressure response to H60+50mmHg and FAO. 
5.1 Participant Characteristics 
Our participants were well matched for gender, age, height, weight, forearm 
circumferences, and MVC such that there were no significant differences in these 
variables between groups for the pre-test.  Additionally there were no significant 
differences between the dominant and non-dominant arms with respect to MVC and 
forearm circumferences at pre-test.  This is in agreement with Mostoufi-Moab et al. 
(1998), Somers et al., 1992, and Sinoway et al., 1996 that showed no significant 
difference in MVc or forearm circumference between dominant and non-dominant arms.  
Our forearm circumference measurements (Non-dominant arm site 1: 26.58±3.31cm; 
site 2: 23.13±3.32cm; site 3: 18.86±2.17cm) were consistent with forearm 
circumferences reported by Sinoway et al., 1996 (Non-dominant arm site 1: 
27.6±0.50cm; site 2: 24.5±0.5cm; site 3: 19.4±0.4cm).   
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5.2 EPR Effect 
5.2.1 Respiratory Rate, HRV, and Blood Pressure 
Respiratory rate did increase significantly during H60+50mmHg (≈+2.82 breaths 
per minute).  This is consistent with results from Fontana et al. (1994) that found an 
approximate 4 breath per minute increase in respiratory rate with isometric handgrip 
activity.  In this study, respiratory rate during post-exercise forearm occlusion was not 
significantly different from SB1.  To our knowledge there are no previous studies 
measuring respiratory rate during forearm occlusion.  Due to the possibility that HRV 
measurement may be effected by a change in respiratory rate, it was subsequently 
used as a covariate for the EPR effect analyses.   
We found approximately a 20 beat per minute increase (Mean R-R≈233.11msec) 
in heart rate during H60+50mmHg.  This was consistent with Victor et al. (1987) which 
found a 13 beat per minute increase in heart rate during dynamic handgrip exericse at 
30% MVC (0.7hz) with 50mmHg on the arm and Mostoufi-Moab et al. (1998) that found 
a 12 beat per minute increase in heart rate with dynamic handgrip exericse at 25%MVC 
(0.25hz) with 50mmHg of pressure on the arm.  During FAO, mean R-R decreased 
below H60+50mmHg, but remained significantly elevated above SB1 (≈6beats per 
minute).  This is in contrast to findings by Somers et al. (1992), Iellamo et al. (1999), 
Fisher and White (1999), Victor et al. (1987), Seals (1989), Victor and Seals (1989), and 
Strange (1999) which found that heart rate during FAO was not significantly different 
from SB1.   One reason for this discrepancy is the method by which heart rate was 
measured.  In the current study we used the mean R-R interval as a measurement of 
heart period as opposed to mean heart rate used in the studies listed above.  From 
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previous work in this lab we have determined that the standard error of the mean for 
Mean R-R interval is less than 56 miliseconds, thereby allowing us to detect small 
changes in heart period (Kluess et al., 2002). Although not reported as significantly 
different from SB1, the reported mean differences between FAO and SB1 for the above 
mentioned studies (2 and 5 beat per minute higher heart rates during FAO), were 
similar to the magnitude of change reported in this study (≈6 beats per minute), 
There have been no previous studies reporting SDNN change during 
H60+50mmHg.  However, the SDNN at SB1 was similar to a previous study in this lab 
using similar participant demographics and tachogram time period for analysis (Kluess 
et al., 2002).  Additionally, the magnitude of change in SDNN with H60+50mmHg in the 
current study was 1.5-fold greater than in our previous study where there was no 
forearm occlusion during exercise (Kluess et al., 2002).  SDNN returned to SB1 levels 
during FAO which was an expected change considering that SDNN calculated for less 
than five minutes is believed to more strongly reflect changes in parasympathetic 
activity (Task force, 1996, Kluess et al., 2000).   
For the variables LFnu and MAP the following discussion will focus on the 
behavior of these variables in reference to the hypotheses regarding cardiovascular 
responses consistent with stimulation of the EPR and comparison to other literature.   
Post-exercise occlusion is commonly employed to quantify the EPR (McClosky 
and Mitchell, 1972; Victor et al., 1987; Hayward, Wesselmann, Rymer, 1991; Somers et 
al., 1992; Seals, 1989; Victor and Seals, 1989; Fisher and White, 1999; Strange, 1999).  
The theory is that if EPR plays a significant role in the muscle sympathetic and 
cardiovascular responses to exercise, then occluding the blood flow to the muscle after 
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cessation of the exercise will result in a persistent elevation of muscle sympathetic 
activity and blood pressure due to continued stimulation of group IV afferents by the 
metabolites trapped in the muscle (Victor and Seals, 1989).   
This effect has been demonstrated in both isometric and dynamic exercise using 
afferent, efferent, and end-organ models  (Seals, 1989; Somers et al., 1992; Victor and 
Seals, 1989).  Our finding that MAP was elevated above SB1 during FAO is consistent 
with the idea that our exercise protocol (H60+50mmHg) sufficiently stimulates the EPR.  
However, we also expected to see an elevation in LFnu, an index of sympathetic 
activity, during FAO.  Despite an elevation of LFnu during H60+50mmHg, LFnu did not 
remain elevated above SB1 during FAO.   
The present findings initially appear to stand in contrast to Iellamo et al. (1999) 
who found a persistent elevation in low frequency power (ms2) and low frequency 
normalized units during post-exercise occlusion.  Interestingly, however, the change 
from spontaneous breathing (LFnu=63.8%) to exercise (LFnu=82.8%) in Iellamo et al. 
(1999) was similar to that of the present study (pre-train non-dominant arm LFnu 
SB1=53.43%; H60=73.62%).  The statistical significance observed in Iellamo, et al. 
(1999) might have been aided by their use of isometric single-leg exercise, while the 
present study employed dynamic handgrip exercise.  The use of a larger muscle mass 
and an isometric challenge may have provided a greater stimulus for an EPR response.  
The effect of muscle group size on sympathetic activity has been previously 
studied by Seals (1993) who showed that the MSNA, heart rate, and blood pressure 
responses to isometric handgrip exercise were greater than that for isometric finger 
flexion exercise, despite relative intensity and perceived effort being the same.  This 
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relationship between muscle group size and magnitude of cardiovascular and 
sympathetic response to exercise also holds for dynamic exercise.  Victor et al. (1987) 
had their participants perform dynamic handgrip exercise at 30%MVC which caused a 
5-b/min increase in heart rate and a 7-mmHg increase in MAP, but no change in MSNA 
(Victor et al., 1987).  However, arm cycling exercise at 30% of max resulted in a 32-
b/min increase in heart rate, a 12-mmHg increase in MAP, and a 25 burst/minute 
increase in MSNA (Victor and Seals, 1989).   
Further, when these findings are paired with post-exercise occlusion to 
specifically target the EPR, leg activity (dynamic or isometric) always results in 
persistent elevation of blood pressure during post-exercise occlusion (Iellamo et al., 
1999; Fisher and White, 1999; Strange, 1999).  However, dynamic handgrip exercise 
only induces persistent elevation of blood pressure when the intensity is at least 
60%MVC (1hz contraction speed) or the forearm is occluded during the activity (Victor 
and Seals, 1989; Victor et al., 1987). Therefore, the muscle group exercised appears to 
play a role the cardiovascular and autonomic response to exercise and the ability of 
HRV to detect these changes.  
The mode by which this change in signals from parasympathetic withdrawal 
during activity to an increase in parasympathetic activity during recovery, despite 
continued EPR signaling, is not entirely understood.  It is known that dynamic exercise 
increases the activity of both group III and IV afferents, however, group III afferents are 
mostly inactive during post-exercise occlusion.   
Work by Potts and Mitchell (1998) suggests that the movement detection (group 
III afferents) aspect of the EPR influences baroreceptor resetting during exercise and 
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therefore, when that stimulus is removed the barorecepetor reflex acts to slow heart 
rate.  Regardless of the specific mechanism, it is plausible that since the skeletal 
muscle vasculature does not contain parasympathetic innervation, MAP remains high 
as a consequence of heightened sympathetic activity.  However, in the heart, where 
vagal activity has a dramatic chronotropic effect, spectral parameters of HRV may not 
provide a clear measure of sympathetic changes. This is particularly true during periods 
where both sympathetic and parasympathetic activity is elevated above the baseline (or 
comparison condition).   The reason for this is that LFnu is calculated as LF power in 
relation to the change in HF power.  Therefore a decrease in LFnu during FAO can 
indicate any one of the following: 1) an increase in HF with no change in LFpower; 2) an 
increase in HF with a decrease in LF power, or 3) an increase in the power of both HF 
and LF power such that the magnitude of change in HF power is greater than the 
change in LF power.   
As mentioned, the present investigation involved dynamic exercise, while Iellamo 
et al. (1999) employed isometric work.  It has been well established that isometric 
exercise induces greater sympathetic, heart rate, and blood pressure response 
compared to dynamic activity at the same workload (Gonzalez-Camarena et al., 2000).   
However, there is evidence that the cardiovascular and autonomic response to 
isometric and dynamic exercise is not the same.  Gonzalez-Camarena et al. (2000) 
compared the HRV response of isometric (30%MVC) and dynamic (30 to 60%VO2max, 
60 rpm, 6 min) quadriceps femoris exercise.  They controlled for both exercise intensity 
(%MVC) and MAP at peak exercise and found that dynamic exercise resulted in an 
overall reduction in HRV power (ms2) and a shift toward the LF domain indicating that 
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the exercise induced parasympathetic withdrawal and an increase in sympathetic 
modulation of the heart.  However, isometric exercise resulted in an overall increase in 
HRV power (ms2) with both an increase in LF and HF power, indicating that there was 
an increase in parasympathetic and sympathetic modulation of the heart.  They 
concluded that the cardiovascular responses to isometric and dynamic exercise are not 
controlled through the same mechanisms and speculated that the baroreceptor reflex 
may play a greater role in isometric compared to dynamic exercise.   This conclusion is 
substantiated by Potts and Mitchell (1998) who found that baroreceptor resetting during 
exercise is influenced by the movement detection aspect of the EPR and therefore, 
baroreceptor resetting may not occur to the same degree with a single isometric 
contraction, compared to multiple dynamic contractions.     
Differences in the muscle group exercised, exercise intensity, and exercise mode 
all appear to alter the relative contribution of the different cardiovascular control 
mechanisms during exercise and forearm occlusion. However, it also may be possible 
to alter cardiovascular control mechanisms while controlling for the above variables.  In 
a previous study, our participants performed handgrip exercise at 60%MVC without 
50mmHg (Kluess et al., 2001).  Interestingly, the change in LFnu from rest to H60 with 
50mmHg of forearm occlusion (Train non-dominant pre: 19.33%) were approximately 
the same as our previous study where the participants performed H60 without forearm 
occlusion (Kluess et al., 2001, control day: 21.20%).  In the previous study (Kluess et 
al., 2002), MAP did not remain elevated above SB1 during FAO, while in the current 
study, this effect did occur.  This finding is important and, according to EPR theory,  
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suggests that forearm occlusion during exercise resulted in greater EPR activation than 
the exercise alone.   
Adreani and Kaufman (1998) using a decerebrate cat model have previously 
demonstrated the effect of occlusion during exercise.  They found that group III and IV 
afferents were directly stimulated with simulated walking activity with and without 
complete arterial occlusion.  However, the magnitude of change in group III and IV 
afferent firing frequency to activity with arterial occlusion was 44% and 47% higher, 
respectively, than simulated walking without arterial occlusion.   
In humans, exercise with reduced metabolite washout has also been used to 
induce EPR activity.  Mostoufi-Moab et al. (1998) used dynamic handgrip exercise at 
25%MVC with and without 50 mmHg of pressure on the arm and found no elevation of 
blood pressure with 25%MVC alone, but found a significant elevation in blood pressure 
when occlusion was present.    
Victor et al. (1987) demonstrated the EPR specificity of this maneuver in 
humans.  They performed dynamic handgrip exercise at 30% MVC with 50mmHg of 
pressure on the arm and found that it resulted in approximately three-fold greater heart 
rate and blood pressure response, compared to exercise with no pressure on the arm.  
Additionally, they found a persistent elevation in blood pressure and MSNA during 
forearm occlusion.  This did not occur when dynamic handgrip exercise at 30%MVC 
was performed without occlusion (Victor and Seals, 1989).  They specifically attributed 
the cardiovascular and muscle sympathetic nerve activity responses to greater 
stimulation of the EPR through increased trapping of metabolites during the activity.  
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Therefore, the contrast between the HRV findings from Illeamo et al. (1999) and 
the current study are most likely explained by differences in muscle group size where a 
larger muscle mass induces an EPR response that persists more completely into 
forearm occlusion.  Evidence from previous studies in this lab and others suggest that 
despite similar increases in sympathetic activity during exercise it is possible to shift the 
relative contribution of cardiovascular control mechanisms through trapping metabolites 
during exercise, altering the mode of exercise, and exercising different muscle groups 
(Iellamo et al., 1999; Gonzalez-Camarena et al, 2000; Kluess et al., 2002).     
5.2.2 Associations Among Variables 
It has been well established that the magnitude of the change in sympathetic 
activity and, to some degree, the cardiovascular response to activity is related to the 
muscle group recruited.  This inference has come primarily from studies that have 
compared different muscle groups (e.g., arms vs. legs).  However, there is no 
information concerning the relationship between muscle mass within the same muscle 
group and cardiovascular and autonomic response to exercise.  Additionally, the 
relationship between muscle mass and the cardiovascular response, as assessed 
during post-exercise forearm occlusion has never been formally reported.   
The working hypothesis for the relationships stated above is that a larger muscle 
mass contains more group III and IV afferents and therefore, the afferent signal is larger 
and signals a greater magnitude cardiovascular response than a smaller muscle mass 
(Seals, 1993; Victor et al., 1987; Victor and Seals, 1989; Fisher and White, 1999; 
Iellamo et al. 1999; Gonzalez-Camarena et al. 2000; Somers et al. 1992; Strange, 
1999).  Therefore we used linear regression to infer if a relationship existed among 
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circumference site 1 (the site closest to the olecranon process) and the change from 
SB1 to H60+50mmHg and the change from SB1 to FAO for the variables Mean R-R, 
SDNN, LFnu, and MAP.   
We found a negative relationship between arm circumference and change in 
Mean R-R from SB1 to H60+50mmHg.  This was accompanied by a positive 
relationship between arm circumference and increase in MAP from rest to 
H60+50mmHg (dominant arm, pre-test).  Both of these relationships are consistent with 
the above stated hypothesis and suggest that a larger muscle mass (as inferred from 
arm circumference) induces a greater cardiovascular response to exercise (of a given 
relative intensity).   
However, we found a positive relationship between forearm circumference and the 
change in Mean R-R from forearm occlusion to SB1 (dominant arm).  Additionally, we 
found a positive relationship between MAP during forearm occlusion and forearm 
circumference (dominant and non-dominant arm).  Therefore, a person with a larger 
arm circumference recovers to a higher heart period during forearm occlusion than 
people with a smaller arm circumference.  The finding that cardiovascular recovery 
(mean R-R) is more rapid with a larger arm circumference suggests that central 
command plays a large role in the cardiovascular response to exercise, compared to a 
smaller forearm circumference.   
Although not previously explored, there is some evidence supporting this 
supposition.  Training studies in the arm have demonstrated that training adaptations 
are localized to the arm used and attributed to changes in EPR (Somers et al., 1992; 
Mostoufi-Moab et al., 1998; Sinoway et al., 1996).  However, studies using leg training 
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(single leg and both legs) have found significant changes in central command, but no 
detectable changes in EPR (Fisher and White, 1999; Seals and Chase, 1989).   
Although it is difficult to directly relate these chronic studies to the current acute study it 
does set a precedent for larger muscle masses having a greater influence on central 
command.  
In contrast to Mean R-R, MAP remained higher with a larger muscle mass and is 
consistent with the hypothesis that larger muscles have greater magnitude change 
consistent with the EPR effect.  The association between forearm circumference and 
the behavior of Mean R-R and MAP during H60+50mmHg and FAO hypothetically 
indicate that the EPR and central command are not entirely redundant mechanisms and 
under certain circumstances can act in opposition to each other.   
  Uniquely, we found that the cardiovascular response to exercise and forearm 
occlusion in a single muscle group is consistent with the idea that cardiovascular 
response is subject to significant variation in the predominant mechanism of 
cardiovascular control despite maneuvers to emphasize a single mechanism.  These 
findings further underscore the complexity of studying mechanisms of cardiovascular 
control in humans.  
5.3 The Effect of Training 
The second part of this study was to evaluate the influence of non-dominant 
handgrip exercise training on cardiovascular response to exercise and post-exercise 
forearm occlusion.  As expected, we saw no MVC, forearm circumference, blood flow, 
respiratory rate, HRV, or blood pressure changes in the external control group (non-
dominant arm) and the dominant arm of the training group.   
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However, the data did not support our hypothesis that exercise training would 
result in attenuated HRV and blood pressure responses to exercise and FAO in the 
trained arm.  While it would be tempting to speculate that perhaps the training was not 
sufficient to evoke an adaptation per-se, it should be noted that a reduction in vascular 
resistance during RHBF in the trained arm was evident after the training period.   
5.3.1 Participant Characteristics 
There was no significant effect of training on MVC or forearm circumference at 
any of the measured sites.  This is consistent with results from Alomari et al. (2001), 
Somers et al. (1992), Mostoufi-Moab et al. (1998), and Sinoway et al. (1996).   
5.3.2 Blood Flow and Vascular Resistance 
We hypothesized that RHBF would be significantly higher following handgrip 
exercise training in the non-dominant arm.  In contrast to studies by Alomari et al. 
(2001); Sinoway, Shenberger, Wilson, McLaughlin, Musch, Zelis (1987); and Green, 
Cable, Fox, Rankin, Taylor (1994) we did not see a significant change in RHBF 
following exercise training.  However, when a paired T-test was run on the trained arm 
(non-dominant), vascular resistance during RHBF was lower following the training 
period.  While providing only a weak inference, such a training adaptation would be 
consistent with previous published data from our laboratory (Alomari et al., 2001).   
5.3.3 Respiratory Rate, HRV, and Blood Pressure 
There was no significant effect of training for respiratory rate and SDNN for 
∆H60+50mmHg or ∆FAO.  To our knowledge, there are no previous studies concerning 
the changes in respiratory rate and SDNN under conditions similar to the current study. 
While we did see a trend towards a training adaptation in SDNN, this parameter is 
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primarily thought of as a marker of parasympathetic activity, and therefore it is not likely 
to be addressing EPR per-se. Additionally, there was no training effect with Mean R-R 
during either ∆H60+50mmHg or ∆FAO.  This finding is in agreement with studies by 
Mostoufi-Moab et al. (1998), Sinoway et al. (1996), and Somers et al. (1992) which also 
found no difference in mean R-R at rest and during exercise.    
In contrast to our hypothesis, the response of LFnu was not attenuated during 
either  ∆H60+50mmHg or ∆FAO following training.  As discussed previously, our HRV 
measurements under the conditions used during this study were complicated by two 
main factors: a) the high vagal activity in the heart dampening the ability to see 
peripheral sympathetic changes and b) a previously unreported association between 
arm circumference and predominant cardiovascular mechanism complicated 
interpretation of the data.  As a result of these problems it was highly unlikely that we 
would see the hypothesized attenuation of HRV response to the conditions. 
Additionally, we calculated the type II error rate for LFnu during ∆H60+50mmHg 
or ∆FAO (see appendix F).  This indicated that we had sufficient power to detect 
changes with ∆H60+50mmHg, but with ∆FAO we had a 52% chance of a type II error. 
The elevated type II error rate was likely due to nearly significant pre-test differences. 
Regardless, this finding does not interfere with the inference that exercise training did 
not attenuate the response in LFnu (See appendix F, tables F.3 and F.4).  
However, in agreement with others, we did not see attenuation in HRV response 
to the conditions in the dominant arm (Somers et al., 1992; Alomari et al., 2001; 
Sinoway et al., 1996).  No change in the dominant arm, despite training in the non-
dominant arm, does suggest that central command was not altered by our handgrip 
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exercise training protocol.  This finding is in contrast to Fisher and White (1999) that 
found a change in central command using single leg training.  These disparate findings 
may be the result of differences in cardiovascular control by muscle group and size.   
Despite the problems experienced with HRV variables we observed an EPR 
effect during FAO in MAP and expected to see an attenuation of MAP response with 
training.  However, we observed no main effect of treatment for MAP.  A post-hoc 
calculation of the type II error rate revealed that we had a 34.7% chance of committing a 
type II error on the treatment by group interaction (see appendix F). However, this 
slightly elevated type II error rate does not weaken our inference about a lack of a 
training effect in that the mean responses in MAP in the trained arm (non-dominant) 
were very close in magnitude (Pre-test: 18.17mmHg; post-test: 19.21mmHg). No MAP 
changes with handgrip exercise training is in contrast to studies by Sinoway et al. 
(1996) and Mostoufi-Moab et al (1998) that report a decreased MAP during handgrip 
exercise testing.  There are several differences between the current study and those by 
Sinoway et al. (1996) and Mostoufi-Moab et al. (1998) including the intensity of the 
handgrip exercise, the length of time of the exercise bout, and the contraction speed.   
The exercise intensity used during training and during testing in studies by 
Mostoufi-Moab et al. (1998) and Sinoway et al. (1996) were much lower than that used 
in the current study.  However, Mostoufi-Moab et al. (1998) and Sinoway et al. (1996) 
did have participants exercise to fatigue during the training sessions, while our 
participants were limited to 20 minutes per training session.  Despite the limitation in 
time for our subjects, the initial exercise intensity was 2-fold greater than Sinoway et al. 
(1996) and Mostoufi-Moab et al. (1998) and the first week most participants were 
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fatigued (drop in force produced of more than 10 units) in under 20 minutes (average 
training time for the first week was17±5 minutes).  Additionally, the reported average 
rating of perceived exertion for the first week of training was 15 (Hard) and for the last 
week was 17 (very hard).  These data, although weak, suggest that our training protocol 
was fatiguing and perceived as effortful.  Therefore, it is difficult to explain the 
differences in MAP results among studies exclusively to training intensity and exercise 
session duration  
Another difference between this study and previous studies is the 
contraction/relaxation speed during the training.  Sinoway et al. (1996) and Mostoufi-
Moab et al. (1998) used 2-second contraction to 3-second release for exercise training 
and found a decrease in MAP during exercise testing.  However, studies such as 
Somers et al. (1992) and the current study used 1-second contraction and 1-second 
release and found no change in MAP during exercise testing.   
The mechanism by which this contrast occurs is not readily apparent and given 
the minimal number of studies it is difficult to attribute attenuation of MAP response with 
exercise training to contraction/relaxation speed.  However, further study regarding the 
effect of contraction/relaxation speed and cardiovascular response to exercise training 
is warranted.  Therefore, it is difficult to conclusively attribute the differences in the MAP 
results to either exercise intensity, exercise session time, or contraction/relaxation 
speed.  However, the influence of the factors should be further studied.   
5.3.4 Limitations 
The findings in this study were limited by a number of factors.  One such factor 
was the difficulty in measuring changes in sympathetic activity in the heart under 
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conditions where the heart is experiencing a marked increase in vagal activity.  This 
factor limited our ability to measure persistent increase in sympathetic activity during 
forearm occlusion.  Additionally, resolution of sympathetic activity during forearm 
occlusion may further have been limited by the use of a small muscle group during 
exercise.  It appears that HRV is a suitable measurement of sympathetic activity during 
forearm occlusion when the leg muscles are used (Iellamo et al., 2000).   
Another limitation was the indication that there is an association between forearm 
circumference and cardiovascular control during exercise and post-exercise forearm 
occlusion.  This finding added significant and previously unappreciated complexity to 
the model of post-exercise forearm occlusion.  This association also potentially limited 
our ability to see training induced changes since not all participants responded in the 
same way to exercise.   
In addition, it is not clear as to the extent to which environmental factors such as 
temperature, relative humidity, and sound contribute to the variability of the parameters 
of interest. Moreover seasonal changes in these parameters have not been fully 
investigated. As to the former, greater environmental control may eliminate some day to 
day variation in parameters. As to the latter, however, it would appear outside of a 




CHAPTER 6 SUMMARY AND CONCLUSIONS 
The purpose of this study was twofold: (1) to examine the cardiovascular 
response to an acute bout of handgrip exercise in as much as it may be reflective of  
stimulation of the EPR; and (2) to evaluate the influence of non-dominant handgrip 
exercise training on cardiovascular response to exercise and post-exercise forearm 
occlusion. The cardiovascular responses observed in this study were consistent with the 
hypothesis that the EPR was stimulated during exercise.  However, the resolution of 
HRV measurements during post-exercise forearm occlusion was complicated by the 
large chronotropic influence of vagal activity on the heart.  Uniquely, we found that the 
cardiovascular response to exercise and forearm occlusion in a single muscle group is 
subject to significant variation in the predominant mechanism of cardiovascular control 
despite maneuvers to emphasize a single mechanism.  These findings further 
underscore the complexity of studying mechanisms of cardiovascular control in humans.  
 With respect to the influence of exercise training, we hypothesized that exercise 
training would result in attenuated HRV and blood pressure responses to exercise (H60 
+50mmHg) and post-exercise forearm occlusion (FAO) in the trained arm.  However, 
the data do not support this hypothesis.  Additionally, we did not see the hypothesized 
increase in reactive hyperemic blood flow following exercise training.  However, using a 
less rigorous statistical test we did see a decrease in forearm vascular resistance during 
the reactive hyperemia condition.  This finding is in agreement with other studies using 
single arm handgrip exercise training and suggests that the training protocol did induce 
a physiological adaptation.   
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 In conclusion, we were successful in using HRV to measure autonomic changes 
during exercise.  The failure of HRV to measure persistent sympathetic activity 
expected during post-exercise forearm occlusion suggest that HRV may not be a good 
tool to use with small muscle exercise in subjects with apparently healthy cardiovascular 
control mechanisms.  However, it is possible that this model will provide good resolution 
during post-exercise forearm occlusion in populations, such as heart failure patients or 
the elderly, where autonomic function is compromised.   
 One very important finding of this study was the association between forearm 
circumference and cardiovascular control.  This association, particularly during post-
exercise forearm occlusion, requires further study and possibly requires a re-evaluation 
of the cardiovascular control mechanisms involved in post-exercise forearm occlusion.   
 Although limited, we did see a decrease in vascular resistance in the trained arm 
and an increase in endurance time of the training sessions suggesting that a training 
effect did occur in our participants.  However, the training effect observed could not be 
linked to a change in EPR.   
 Further work needs to be done to more completely characterize EPR 
under conditions of exercise and post-exercise forearm occlusion before these 
conditions can be used conclusively to indicate changes in EPR both acutely and 
chronically.  Additionally, the adaptability of the EPR has not been conclusively shown 
in either handgrip or leg exercise training and requires further study.   
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Protocol Abstract 
The role of Aspirin in the secondary prevention of myocardial infarction is 
well-established (Elwood et al., 1998).  The steering committee of the Physician’s 
Health Study Research Group (1989) reported a 44% reduction in the risk for 
myocardial infarct in individuals randomized to Aspirin.  Although the mechanism 
for the reduction in risk of myocardial infarct is not entirely understood, Aspirin 
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has a powerful antithrombic effect.  Aspirin rapidly inhibits prostaglandin 
formation in blood platelets by inactivating fatty acid cyclooxygenase.  As a result 
of this inhibition, Aspirin prevents the synthesis of thromboxane A2, a 
vasoconstrictor and platelet activator.  Thus, Aspirin therapy appears to prevent 
platelet aggregation and subsequent thrombosis.   
However, along with the blockade of platelet cyclooxygenase, Aspirin also 
blocks the synthesis of prostaglandins in vascular tissue.  Prostacyclin, a 
prostaglandin, is a potent vasodilator and platelet inhibitor.  Aspirin therapy 
inactivates platelet cyclooxygenase for the life of the platelets (approximately 10-
12 days) (Ali, 1995).  In contrast, vascular tissues can resynthesize 
cyclooxygenase after exposure to Aspirin, and thus regain the capacity to form 
prostaglandins.  The ability of vascular tissue to resynthesize cyclooxygenase is, 
in part, dependent on the dose of Aspirin administered.  Evidence suggests that 
Aspirin given in doses less than 325 mg/day is insufficient to block prostaglandin 
synthesis (Gajados et al., 1998, Physician’s Health Study Research Group 1989, 
Aspirin Myocardial Infarction Study Research Group, 1980).  Therefore, vascular 
reactivity should be preserved, in contrast to doses exceeding 325 mg/day.  
Interestingly, there is some evidence that Aspirin and related non-steriodal anti-
inflammatory drugs (NSAIDs) in high doses (50 mg per kg of body weight) 
attenuates HR and blood pressure responses to exercise by blocking chemically 
sensitive receptors in the interstitium of the skeletal muscle (Fontana et al., 1994; 
Rotto et al., 1990).  Combined, the reduced vascular reactivity and blunted  
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hemodynamic response to exercise may result in reduced blood flow to tissue 
and subsequently contribute to symptoms of exercise intolerance and fatigue.   
In light of these studies, attempts have been made to maximize the 
beneficial effects in antithrombic therapy using alternative regimes like low dose 
Aspirin, alternate day Aspirin, and control release Aspirin (Physician’s Health 
Study Research Group, 1989; Elwood et al., 1998).  Interestingly, data is lacking 
on the effect of Aspirin therapy on cardiovascular function, such as heart rate, 
blood pressure, and blood flow.  Knowledge regarding the effects of Aspirin on 
cardiovascular function may be clinically useful in further determining the efficacy 
in patients with or at risk for occlusive vascular disease. This lab has previously 
established a dynamic handgrip exercise protocol through which heart rate and 
blood pressure responses are predictable (Kluess et al., 2000) and reliable 
(Wood et al., 2000).  In Spring 2001 we conducted a study concerning the effect 
of a single dose of Aspirin on acute cardiovascular and blood flow response to 
exercise.  We found that 650 mg of Aspirin decreased heart rate response to 
both rest and forearm occlusion, but did not influence blood pressure response or 
blood flow. 
It is well established that exercise training results in a decrease in both 
heart rate and blood pressure response to exercise (Sinoway et al, 1996; Seals 
and Chase, 1989; Levy et al., 1998; Fisher and White, 1999; Somers et al, 1992).  
However, the mechanisms controlling decreased heart rate and blood pressure 
response to exercise are not well understood. To date only one longitudinal study 
has been performed to evaluate the role of skeletal muscle afferents in 
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cardiovascular control following exercise training (Somers et al., 1992).  They 
found a significant decrease in sympathetic activity during exercise and forearm 
occlusion, but no difference in heart rate and blood pressure response following 
low intensity forearm training.  Since their exercise training stimulus was below 
that which is understood to induce skeletal muscle afferent activity it is possible 
their mixed results were due to inadequate training stimulus (Victor and Seals, 
1989). Forearm occlusion both during and following exercise is a potent and well 
established method to measure the effect of skeletal muscle afferents on 
cardiovascular response (Victor, et al., 1987, Somers, 1992, Iellamo, 1999, 
Fisher and White, 1999, Victor and Seals, 1989).  
Therefore, the purpose of this study is to compare the effect 650-mg of 
Aspirin on heart rate, blood pressure, and blood flow responses to rest, handgrip 
exercise and recovery during forearm occlusion prior to and following 6 weeks of 
exercise training with forearm occlusion.  Such data may provide further 
information regarding hear rate and blood pressure control during exercise.   
The specific aims of the study are: 
1) to determine the effect of 650-mg of Aspirin on cardiovascular response(HR, 
BP, and blood flow) to rest, exercise, and recovery during forearm occlusion prior 
to exercise training; 
2) to determine the effect of 650-mg of Aspirin on cardiovascular response(HR, 
BP, and blood flow) to rest, exercise, and recovery during forearm occlusion 
following exercise training; 
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Participation in this study will not be of any particular benefit to the 
participant.  Rather, it is the purpose of this investigation to further our knowledge 
of how the human body adapts to changes in the environment.   
a) A maximum of 50 volunteers over the age of 18 will be asked to 
participate in this study.  All volunteers will be healthy adults without any over 
signs such as diabetes, heart disease, hypertension, emphysema, 
gastrointestinal disturbances or bleeding or gynecological problems.  Individuals 
with any current medical problems (including those listed above), current 
infection, or on medication known to affect cardiovascular function will be 
excluded from the study. Additionally, anyone that has taken aspirin within two 
weeks prior to testing will be excluded.   
b) All participants will receive a comprehensive explanation of the 
proposed study, its benefits, inherent risks, and expected commitments with 
regard to time.  Following explanation of the proposed study, all participants will 
be required to read and sign the informed consent document during the first visit 
and prior to any experimentation.   
Session 1: Informed consent will be obtained from each participant. The 
participant will undergo an initial risk screening using the Health Status 
Questionnaire that requires the participant to answer questions regarding his 
health history and history of physical activity.  The participant will be measured 
for height and weight. Each participant will be placed in a supine position for 20 
minutes prior to evaluation of forearm vascular blood flow.  
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Forearm blood flow measurements will be obtained from the dominant arm 
using an EC-5R plethysmography system (Hokanson, 1995).  Prior to the 
experiment blood pressure cuffs will be positioned around the participant’s upper 
arm and wrist, and a mercury-in-silastic strain gauge placed around the forearm 
approximately 10 cm distal to the olecranon process.  The forearm will be 
extended and slightly supinated and supported by a Styrofoam block.  
Immediately before the blood flow measurements, hand circulation will be 
occluded for 1 minute by inflating the cuff at the wrist to 240 mmHg.  All blood 
flow measures will be made with an upper arm venous collecting pressure of 50 
mmHg and reported in milliliters per minute per 1000 milliliters of tissue.  
Following the resting blood flow measure, the participant will be asked to 
perform a handgrip exercise task preceded and followed by quiet rest. The 
handgrip exercise tasks consist of squeezing a handgrip measuring device once 
every two seconds at less than maximal effort while the cuff on the upper arm is 
inflated at 50 mmHg for 5 minutes. Lastly, reactive hyperemia following forearm 
occlusion will be achieved by inflating the cuff on the upper arm to 200 mmHg for 
3 minutes.  Blood flow measures will then be determined as described above.  
Throughout the testing procedures, heart rate and blood pressure will be 
recorded. The participant will then be allowed to sit up and asked to ingest 650-
mg of aspirin.  One hour after oral administration of Aspirin, the participant will be 
asked to repeat the protocol described above using the opposite arm.  The 
testing procedures for both arms will last approximately 150 minutes.  
Session 2: The participant will arrive at the lab at least 48 hours following session 
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1.  The protocol for session 1 will be followed except the order of the arms tested 
will be  
opposite to session 1.   
Exercise Training: Participants will report to the laboratory 4 days per week for 6 
weeks. The participant will be asked to perform a handgrip exercise to volitional 
fatigue. The handgrip exercise task consists of squeezing a handgrip measuring 
device once every two seconds at less than maximal effort while the cuff on the 
upper arm is inflated at 50 mmHg for 5 minutes. Each training session will last 
approximately 30 minutes. Session 3: Following 6 weeks of exercise training the 
participants will perform the protocol outlined in session 1.   
Session 4: At least 48 hours after session 3, the participants will be asked to 
perform the protocol outlined in session 2.   
d) There is no risk associated with either the blood flow or exercise testing 
involved in this study.  However, some participants may experience temporary 
discomfort when the blood pressure cuffs are inflated and exercise can result in 
muscle soreness, stiffness, or tightness or in some rare cases muscle injury. 
There is some risk of gastrointestinal disturbances and bleeding with 
administration of Aspirin.  However, in studies that have used 650 mg of 
Aspirin/day or less report a very low incidence of adverse events.  (CARS 
investigators, 1997).   
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PROVIDE ANSWERS TO FOLLOWING QUESTIONS. EITHER LOAD INTO 
WORDPROCESSOR AND INSERT RESPONSES OR ATTACH SHEETS AND 
REFERENCE ALL ITEMS; ANY INAPPLICABLE ITEMS MAY BE SKIPPED 
ONLY BY LISTING THE QUESTION LETTER WITH N/A. (BY SIGNATURE, 
PAGE 1, YOU ARE ATTESTING TO THE ACCURACY OF THE RESPONSES 
TO THESE QUESTIONS.)          
 
A. Why is the use of human subjects necessary (v.s. animals/in vitro)  
The question addressed is specific to the value of cardiovascular response in 
human participants.   
B. Specify sites of data collection.  
Data will be collected in room 20 of the Gym Armory and/or room 54 of the Long 
Fieldhouse under the direction of Dr. Robert Wood, Assistant Professor, LSU, 
Department of Kinesiology. 
C. If surgical or invasive procedures are used, give name, address, and 
telephone number of supervising physician and the qualifications of the person(s) 
performing the procedures. Comparable information when qualified participation 
or supervision is required or appropriate. 
N/A 
D.   Provide the names, dosage, and actions of any drugs or other materials 
administered to the subjects and the qualifications of the person(s) administering 
the drugs. 
 111 
Aspirin 650 mg 
E. Detail all the physical, psychological, and social risks to which the subjects 
may be exposed.  
There are no risks associated with electrocardiography, and non-invasive arterial 
tonometry.  There are no health risks associated with the evaluation of forearm 
blood flow and handgrip exercise, although participants may experience mild 
discomfort during either. Lastly, there are minimal risks associated with aspirin 
administration.   
1) Plethysmography/non-invasive blood flow assessment 
There is no risk associated with venous occlusion plethysmography.  However, 
participants may experience some temporary discomfort during the five minutes 
of forearm occlusion as a result of the 240 mmHg applied to the upper arm. 
Should the participant ask to discontinue this procedure then the upper-arm cuff 
will be deflated immediately. 
2) Handgrip exercise 
Because of the small amount of muscle mass involved in this type of exercise, 
the typical cardiovascular responses involve a modest increase in HR, 
suggesting that this activity is of no greater than moderate in intensity, and 
therefore it is appropriate for all individuals, and poses extremely low health risk 
for the study sample. Handgrip exercise applied according to the methods 
described  may result in mild muscle soreness, muscle stiffness, or tightness, or 
in some rare cases muscle injury.  
3) Aspirin Administration 
 112 
Although rare, allergic reaction may occur with a single dose of aspirin.  While, 
chronic use of Aspirin at 650 mg or less, can result in gastrointestinal 
disturbances and bleeding (0.74 events per 100 people studied).  As is the case 
in this study, the incidence of such adverse reactions is even less in studies with 
short-term exposure (CARS investigators, 1997).   
F. What steps will be taken to minimize risks to subjects? 
The risk associated with handgrip is extremely low, nonetheless proper patient 
screening careful exercise prescription, and appropriate assessment of exercise 
response will ensure that the risks are kept minimal. In addition, the investigator 
will have graduate level training in clinical exercise physiology and will possess 
current CPR certification.  The risk associated with aspirin administration will be 
minimized by careful evaluation of Aspirin sensitivity while recruiting subjects. 
Additionally, anyone that has taken aspirin within two weeks prior to testing will 
be excluded.   
G. Describe the recruitment pool (community, institution, group) and the criteria 
used to select and exclude subjects.  
Participants for this study will be recruited from undergraduate and graduate 
courses in the LSU department of Kinesiology.  A total of 50 volunteers over the 
age of 18 will be asked to participate in this study. All volunteers will be healthy 
adults without any overt signs such as asthma, diabetes, heart disease, 
hypertension, emphysema, gastrointestinal disturbances or bleeding, known 
allergy to Aspirin, or gynecological problems.  Individuals with any current 
medical problems (including those listed above), current infection, or on 
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medication known to affect cardiovascular function will be excluded from the 
study.  
H.List any vulnerable population whose members are included in this 
project (e.g., children under the age of 18; mentally impairedpersons; pregnant 
women; prisoners; the aged.) 
High risk individuals (as defined above) will be excluded from participation in this 
study.   
I. Describe the process through which informed consent will be 
obtained.(Informed consent usually requires an oral explanation, discussion, and 
opportunity for questions before seeking consent form signature.) 
All participants will receive a comprehensive explanation of the proposed study, 
its benefits, inherent risks, and expected time commitments.  Following the 
explanation of the proposed protocol, all participants will be allowed a period of 
questioning.  Individuals who are willing to participate in the study will be required 
to read and sign the informed consent document during the first visit.  Each 
participant will receive a copy of the informed consent form.   
J. (1) Is this study anonymous or confidential? (Anonymous means that the 
identity of the subjects is never linked to the data, directly, or indirectly through a 
code system.) (2) If a confidential study, detail how will the privacy of the subjects 
and security of their data will be protected.  
There is no conflict of interest for the investigators in this protocol. The only 
potential gain to the investigators is the professional benefit from academic 
publication or presentation of the results.  The names and personal information of 
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each participant will not appear in print or will be presented in a manner that 
would not identify the individual.  All documents containing confidential 
information will be kept in a locked cabinet in a locked laboratory.  Only members 
of the research team whose names are indicated herein will be granted access to 
these records.   
CONSENT FORM 
1. Study Title: The Effect of a Single Dose of Aspirin on Cardiovascular 
Responses During Handgrip Exercise and Forearm Occlusion Following 6 
Weeks of Exercise Training 
2. Performance Site:  Department of Kinesiology, Louisiana State University 
3. Investigators:  The following investigators are available for questions at the 
telephone numbers listed below: 
Principal Investigator: 
Robert H. Wood, Ph.D.  
Department of Kinesiology (225) 578-9142 
Co-Investigators: 
Heidi A. Kluess, M.S. 
Department of Kinesiology (225) 578-2036 
4. Purpose of the Study: The purpose of this study is to compare the effect one 
dose of Aspirin on heart rate, blood pressure, and blood flow during: 1) rest, 2) 
less than maximal muscular effort, and 3) during inflation of a blood pressure cuff 
on the participant's upper arm to 240 mmHg for 2 minutes. These measures will 
be made before and after 6-weeks of arm exercise. 
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5. Participant Inclusions: A total of 50 volunteers over the age of 18 will be asked 
to participate in this study.  All volunteers will be healthy adults without any over 
signs such as diabetes, heart disease, high blood pressure, lung disease, 
digestive disturbances or bleeding, or female reproductive problems.   
6. Participant exclusions: Individuals with any current medical problems 
(including those listed above), current infection, or on medication known to affect 
heart or blood vessels will be excluded from the study. Additionally, anyone that 
has taken aspirin within two weeks prior to testing will be excluded.   
7. Description of the Study: The proposed study consists of 4 separate visits to 
the laboratory over a 4-month period and 24 sessions of exercise training.  Each 
visit is expected to last approximately 2.5 hours.  After informed consent is 
obtained, the participant will be asked to answer questions regarding his health 
history, history of physical activity, and will be measured for height and weight.  
Pre-test Session 1: Each participant will be placed in a supine position and asked 
to squeeze a handgrip-measuring device as tightly as possible. Following 20 
minutes of quiet rest, forearm blood flow measurements will be obtained.  Prior to 
the experiment blood pressure cuffs will be positioned around the participant's 
upper arm and wrist, and a band placed around the forearm to measure blood 
flow. Before blood flow measurements are taken, the blood pressure cuff on the 
wrist will be inflated to 240 mmHg for 1 minute.  Following this, the upper arm 
cuff will be inflated to 50 mmHg for approximately 10 seconds and a blood flow 
measurement taken.  
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Following 5 minutes of quiet rest, the cuff on the participants upper arm 
will be inflated to 50 mmHg and they will be asked to perform a handgrip exercise 
task consisting of squeezing the hand grip measuring device once every two 
seconds at less than maximal effort to fatigue. Immediately following the 
handgrip exercise bout, the cuff on the upper arm will be inflated to 200 mmHg 
for 2 minutes.  Blood flow measures will then be determined as described above.  
During rest, the performance of the handgrip exercise task, and forearm 
occlusion the measurements of heart rate, heart rhythm, and blood pressure will 
be obtained using a blood pressure measuring device on the wrist.  The 
participant will then be asked to ingest 650 mg of Aspirin.  Following one hour of 
quiet rest, the opposite arm of the participant will be testing using the protocol 
described above.  The testing procedures will last approximately 150 minutes.  
Pre-test Session 2: The heart rate, blood pressure, and blood flow responses to 
handgrip exercise and cuff inflation will be tested using the protocol described in 
session 1, but the order of the arms tested will be opposite to session 1.   
Exercise training: Participants will be asked to perform 16 sessions of handgrip 
exercise training over a 6-week period. The participant will be asked to perform a 
handgrip exercise task consisting of squeezing the hand grip measuring device 
once every two seconds at less than maximal effort while the cuff on the upper 
arm is inflated to 50 mmHg. Each session will last approximately 30 minutes.    
Post test Session 3 and 4: Following 6 weeks of exercise training, participants 
will be tested using the protocol outlined in sessions 1 and 2 above.   
8. Benefits: Participation in this study will not be of any particular benefit to the 
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participant.  Rather, it is the purpose of this investigation to further our knowledge 
of how the human body adapts to changes in the environment.   
9. Risks:  There are no known risks associated with obtaining heart rate, heart 
rhythm, and blood pressure. The risks associated with this protocol can be 
broken down into risk associated with the evaluation of forearm blood flow, the 
handgrip exercise testing component, and Aspirin administration.  
a) Plethysmography/Non-invasive blood flow assessment 
There is no health risk associated with the procedures involved in this study. 
However, participants may experience some temporary discomfort when the 
blood pressure cuff is inflated prior to the measurement of forearm blood flow.   
b) Handgrip exercise testing and training 
The risk of handgrip exercise testing using the methods described are minimal in 
this population, but include muscle soreness, muscle stiffness or tightness, or in 
some rare cases muscle injury.  The risk of this study will be minimized as a 
result of proper evaluation, education, and treatment, careful handgrip exercise 
prescription, and appropriate assessment of handgrip exercise responses, the 
presence of well trained personnel capable of monitoring handgrip exercise 
equipment, and a person trained in CPR available while subjects are being 
tested.   
c) Aspirin administration  
Although rare, allergic reaction may occur with a single dose of Aspirin. Regular 
use of Aspirin can result in digestive disturbances and bleeding.  However, 
studies that have used daily doses of 650 mg of Aspirin or less report a very low 
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chance of allergic reaction and digestive disturbances (0.74 events per 100 
people studied).  The incidence of reactions to Aspirin is even less in studies with 
short-term exposure.   
10. Right to refuse: Participation in this study is completely voluntary and 
participants may withdraw at any time without penalty.   
11. Privacy: Though the results of this study may be published, the privacy of the 
participants will be protected and their identities will remain confidential.   
12. Release of Information: The records for each participant in this study may be 
reviewed by investigators, but participant identity will be kept confidential.  The 
data collected will only be used for purposes stated in this consent form.   
13. Financial Information: There is no monetary cost to participate in this study 
nor will any payment be rendered to participants. The study has been discussed 
with me and all my questions have been answered. I may direct additional 
questions regarding study specifics to the investigators. If I have questions about 
subjects' rights or other concerns, I can contact Robert C. Mathews, Chairman, 
LSU Institutional Review Board, (225)388-8692. I agree to participate in the study 
described above and acknowledge the researchers obligation to provide me with 
a copy of this consent form if signed by me.  
_________________________         ________________ 
Participant’s signature    date 
_________________________         ________________ 
Witness signature     date 
_________________________         ________________ 
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Investigator’s signature    date 
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APPENDIX B MEDICAL HISTORY QUESTIONNAIRE 
Fall 2001 
Participant Medical History  
 
The effect of a single dose of aspirin on cardiovascular responses during 
handgrip exercise and forearm occlusion on 4 weeks of exercise training  
 
Name : ______________________ Date: ____________  Phone number: 
_______________ Age: _________   Gender:  Male    Female   Race: 
Cauc.  Afr.Am other ___________ 
Height: _______ Weight: ________ 
 
Has the participant ever been diagnosed with: 
       Yes    No 
CVD 
Hypertension      ____    ____ 
Diabetes      ____    ____ 
Emphysema      ____    ____ 
Asthma      ____    ____ 
Hyperlipidemia     ____    ____ 
Epilepsy      ____    ____ 
Heart Failure      ____    ____ 
Osteoarthritis     ____    ____ 
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Rheumatoid Arthritis     ____   
 ____ 
Peripheral Vascular Disease    ____   
 ____ 
Anemia      ____    ____ 
Signs or symptoms of hypoglycemia   ____   
 ____ 
Surgery on arms or hands    ____    ____ 
 
24 Hour History: 
How much sleep did you get last night? (Please circle one) 
 1 2 3 4 5 6 7 8 9 10      
(Hours) 
 
How much sleep do you normally get? (Please circle one) 
 1 2 3 4 5 6 7 8 9 10      
(Hours) 
When did you last have: 
A cup of coffee or tea   _________________________ 
Eat food    _________________________ 
Smoke a cigarette, cigar, or pipe _________________________ 
Aspirin, ibuprofen, or other drugs _________________________ 
Drink alcohol    _________________________ 
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Any recent illness   _________________________ 
Exercise    _________________________ 
 
Describe your general feelings today.  (Circle one) Excellent Very Good
 Good  
Neither bad nor good Bad Very bad Very, very bad  Terrible 
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APPENDIX C SUPPLEMENTAL DIAGRAMS FOR METHODS 






Plethysmograph Colin BP monitor 
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Diagram C.3: Example of blood pressure wave with labels for systolic and 
diastolic blood pressure 
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APPENDIX D FIGURES FOR THE INDIVIDUAL RESPONSES IN THE 
TRAINING GROUP IN THE NON-DOMINANT ARM DURING H60+50MMHG 
AND FAO PRE-TRAINING AND POST TRAINING FOR MEAN R-R, LFNU, AND 
MAP 
 
Figure D.1: Individual responses for the change in  mean R-R 
(msec) from SB1 to H60+50mmHg before (pre) and after (post) 
training in  the non-dominant arm of the training group .  The 

































Figure D.2: Individual responses for the change in  mean R-R 
from SB1 to FAO before (pre) and after (post)  training in  the 
non-dominant arm of the training group .  The bold line 
































Figure D.3: Individual responses for the change in  LFnu from 
SB1 to H60+50mmHg before (pre) and after (post)  training in 
the non-dominant arm of the training group .  The bold line 




































Figure D.4: Individual responses for the change in  LFnu from 
SB1 to FAO before (pre) and after (post)  training in  the non-
dominant arm of the training group .  The bold line indicates the 





























Figure D.5: Individual responses for the change in  MAP from 
SB1 to H60+50mmHg before (pre) and after (post)  training in 
the non-dominant arm of the training group .  The bold line 





































Figure D.6: Individual responses for the change in  MAP from 
SB1 to FAO before (pre) and after (post)  training in  the non-
dominant arm of the training group .  The bold line indicates the 





























APPENDIX E ABSOLUTE VALUES FOR POST-TEST 












SB1 16.79±2.83 16.59±3.59 16.11±3.97 
H60+50mmHg 20.29±5.59 20.59±5.95* 19.88±5.36* 
FAO 14.71±5.36H 15.00±4.35H 15.33±3.50H 
Mean±standard deviation 
H different from H60+50mmHg 
* different from SB1 
Table E.2: The effect of condition on mean R-R by group and arm (post-test 
only). 








SB1 972.62±122.56 980.95±190.20 998.76±178.86 
H60+50mmHg 751.29±85.10* 744.77±114.95* 775.23±95.36* 
FAO 912.88±149.68H 897.51±144.80H 948.34±150.79H 
Mean±standard deviation 
H different from H60+50mmHg  
* different from SB1 
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Table E.3: The effect of condition on SDNN by group and arm (post-test only). 








SB1 101.44±46.76 87.76±36.77 103.21±47.28 
H60+50mmHg 49.01±25.83 46.76±40.14* 53.61±35.36* 
FAO 103.83±71.10 96.99±47.85H 102.84±52.98H 
Mean±standard deviation 
H different from H60+50mmHg  
* different from SB1 
Table E.4: The effect of condition on LFnu by group and arm (post-test only). 








SB1 56.34±16.57 55.44±22.46 61.89±19.49 
H60+50mmHg 69.91±20.61 76.18±13.33* 70.55±16.18* 
FAO 57.95±20.62 61.60±17.50H 51.55±17.10H 
Mean±standard deviation 
H different from H60  
* different from SB1 
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Table E.5: The effect of condition on MAP by group and arm (post-test only).  








SB1 80.08±8.72 78.27±20.95 78.41±12.26 
H60+50mmHg 97.55±14.40* 97.69±23.63* 92.85±13.67* 
FAO 95.17±14.27* 92.33±29.14* 91.44±17.28* 
Mean±standard deviation 
H different from H60+50mmHg 
* different from SB1 
 
Table E.6: The effect of condition on SBP by group and arm (post-test only). 








SB1 121.67±19.69 123.11±19.27 113.48±16.07 
H60+50mmHg 135.11±22.07 136.75±23.06* 129.58±19.59* 
FAO 132.52±23.06 132.10±31.21 126.65±26.47 
Mean±standard deviation 
H different from H60+50mmHg  
* different from SB1 
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Table E.7: The effect of condition on DBP by group and arm (post-test only). 








SB1 69.44±20.33 62.86±19.77 62.56±16.41 
H60+50mmHg 80.73±13.55 80.24±22.95* 77.00±13.20* 
FAO 78.52±15.47 70.65±28.17 72.23±16.39 
Mean±standard deviation 
H different from H60+50mmHg  
* different from SB1 
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APPENDIX F POST HOC POWER ANALYSIS 
Table F.1: Mean , standard deviation, confidence interval, and type II error rate  for MAP during 
)H60+50mmHg 











pre 28.85 5.63 17.34 40.35 
External 
Control 
post 17.47 3.61 10.09 24.84 
Training  pre 18.17 5.01 7.72 28.61 
Training post 19.21 3.27 12.51 25.90 
Type II error rate for the interaction of Treatment  by  group = 0.347 
Type II error rate for the main effect of Treatment = 0.256 
Type II error rate for the main effect of Group = 0.136 
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Table F.2: Mean , standard deviation, confidence interval, and type II error rate  for MAP during 
)FAO 











pre 16.48 5.76 4.70 28.27 
External 
Control 
post 15.09 4.67 5.55 24.64 
Training  pre 17.82 5.23 7.12 28.51 
Training post 15.30 4.24 6.64 23.96 
Type II error rate for the interaction of Treatment by group = 0.052 
Type II error rate for the main effect of Treatment = 0.077 
Type II error rate for the main effect of Group = 0.052 
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Table F.3: Mean , standard deviation, confidence interval, and type II error rate  for LFnu during 
)H60+50mmHg 











pre 16.83 4.42 7.80 25.86 
External 
Control 
post 13.32 5.72 1.63 25.01 
Training  pre 20.00 3.51 12.82 27.17 
Training post 20.74 4.54 11.45 30.03 
Type II error rate for the interaction of Treatment  by  group = 0.072 
Type II error rate for the main effect of Treatment = 0.059 
Type II error rate for the main effect of Group = 0.204 
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Table F.4: Mean, standard deviation, confidence interval, and type II error rate for LFnu during 
∆FAO 











pre 8.43 4.86 -1.50 18.36 
External 
Control 
post -0.01 4.97 -10.25 10.06 
Training  pre -7.26 4.02 -15.47 0.96 
Training post -6.16 4.11 -14.56 2.24 
Type II error rate for the interaction of Treatment  by  group = 0.251 
Type II error rate for the main effect of Treatment = 0.168 
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